Atopic Dermatitis
Conditions
Keywords
Mild-to-Moderate Atopic Dermatitis, topical
Brief summary
This study is being conducted to provide data on efficacy, safety, tolerability and PK of multiple topical formulation concentrations of PF-06700841 topical cream in the treatment of mild to moderate atopic dermatitis (AD). The study is intended to enable selection of the dose and dosing regimen (once daily \[QD\] vs twice daily \[BID\] application) for the future clinical development of topical PF-06700841.
Interventions
PF-06700841 topical cream
Vehicle topical cream
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinical diagnosis of Atopic Dermatitis for at least 3 months * Investigator's Global Assessment (IGA) Score of 2 or 3 * Eczema Area Severity Index (EASI) score of 3-21 * Body Surface Area (BSA) of 2-20% * Peak pruritus-Numerical Rating Scale (PPNRS) of Grade 2 or more
Exclusion criteria
* Other forms of dermatological diseases (other than atopic dermatitis) * Fitzpatrick skin type score greater than 5 * Clinically significant abnormal ECG, vital signs, and laboratory values * Infection with HBV, HCV, herpes zoster or tuberculosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | Baseline, Week 6 | EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | Baseline, Week 6 | EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD. |
| Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | Baseline, Weeks 1, 2, 3, 4 and 6 | The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch. |
| Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | Baseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch. |
| Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | 4 body regions were evaluated: head and neck, upper limbs, trunk (including axillae and groin) and lower limbs (including buttocks). Scalp, palms and soles were excluded. BSA was calculated using handprint method. Number of handprints (size of participant's full palmer hand) fitting in the affected area of a body region was estimated. Maximum number of handprints were 10 for head and neck, 20 for upper limbs, 30 for trunk and 40 for lower limbs. Surface area of body region equivalent to 1 handprint: 1 handprint was equal to 10% for head and neck, 5% for upper limbs, 3.33% for trunk and 2.5% for lower limbs. Percent BSA for a body region was calculated as = total number of handprints in a body region \* % surface area equivalent to 1 handprint. Overall % BSA for an individual: arithmetic mean of % BSA of all 4 body regions, ranged from 0 to 100%, with higher values representing greater severity of AD. |
| Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | Baseline, Weeks 1, 2, 3, 4 and 6 | EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD. |
| Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11) | An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly; medically important events. Treatment-emergent were events between first dose of investigational product and up to 28 days after the last dose of investigational product that were absent before treatment or that worsened relative to pretreatment state. AEs included both SAEs and all non-SAEs. |
| Number of Participants With Pre-defined Criteria For Vital Signs | Baseline up to Week 6 | Pre-defined criteria included: 1) Diastolic blood pressure (DBP), a) sitting DBP: change of \>= 20 millimeter of mercury (mmHg) increase, b) sitting DBP: change of \>=20mmHg decrease, c) supine DBP: less than (\<) 50 mmHg, d) supine DBP: change of \>= 20mmHg increase, e) supine DBP: change of \>= 20mmHg decrease; 2) Systolic blood pressure (SBP), a) sitting SBP: \<90 mmHg, b) sitting SBP: change of \>=30mmHg increase, c) sitting SBP: change of \>=30mmHg decrease, d) supine SBP: change of \>=30mmHg increase, e) supine SBP: change of \>=30mmHg decrease and f) Supine SBP: value \<90mmHg. |
| Number of Participants With Laboratory Abnormalities | Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11) | Hemoglobin (HGB),hematocrit,erythrocytes (ery.),HDL cholesterol (chl.)\<0.8\*lower limit of normal(LLN);reticulocytes (ret.), ret./ery. (%)\<0.5\*LLN,\>1.5\*upper limit of normal (ULN);ery. mean corpuscular (EMC) volume,EMC HGB,EMC HGB concentration,potassium,chloride,calcium,bicarbonate\<0.9\*LLN,\>1.1\*ULN;platelets\<0.5\*LLN,\>1.75\*ULN;leukocytes (leu.),glucose\<0.6\*LLN,\>1.5\*ULN;lymphocytes (lym.), lym./leu.(%), neutrophils (neu.), neu./leu. (%), protein,albumin \<0.8\*LLN,\>1.2\*ULN;basophils (bas.), bas./leu.(%), eosinophils (eos.), eos./leu., monocytes (mon.), mon./leu.(%), urate \>1.2\*ULN;bilirubin (total, direct, indirect)\>1.5\*ULN;aspartate/alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, alkaline phosphatase\>3.0\*ULN;urea nitrogen, creatinine, triglycerides, chl.\>1.3\*ULN; sodium \<0.95\*LLN,\>1.05\*ULN; creatine kinase \>2.0\*ULN;Urine: pH\<4.5,\>8;glucose, ketones, protein, HGB, urobilinogen,bilirubin,nitrite,leukocyte esterase\>=1;ery., leu.\>= 20;hyaline casts\>1;bacteria\>20. |
| Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | Baseline up to Week 6 | Clinically significant ECG criteria included PR interval: value greater than (\>) 280 millisecond (msec), percentage change greater than equal to (\>=) 25/50 percentage, QRS interval: value \>120 msec, percentage change \>= 50% and QT interval corrected using the Fridericia's formula (QTCF) value 450 msec and 30\<=change\<60. |
| Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | Baseline, Week 6 | IGA assesses severity of participant's AD on a 5 point scale. 0= clear, no inflammatory signs of AD; 1= almost clear, AD not fully cleared- light pink residual lesions (except post-inflammatory hyperpigmentation), just perceptible erythema, papulation/induration lichenification, excoriation, and no oozing/crusting; 2= mild AD with light red lesions, slight but definite erythema, papulation/induration, lichenification, excoriation and no oozing/crusting; 3= moderate AD with red lesions, moderate erythema, papulation/induration, lichenification, excoriation and slight oozing/crusting and 4= severe AD with deep dark red lesions, severe erythema, papulation/induration, lichenification, excoriation and moderate to severe oozing/crusting. Higher scores indicating more severity of AD. Assessment excluded soles, palms and scalp. |
| Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
| Change From Baseline in Lipids Profile Values at Week 6 | Baseline, Week 6 | Lipid parameters that were assessed: high density lipoprotein (HDL) cholesterol, triglycerides, cholesterol, low density lipoprotein (LDL) cholesterol. |
| Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | Baseline, Week 6 | Mean change in total cholesterol/HDL cholesterol ratio was assessed and reported. |
| Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline, Weeks 2 and 6 | — |
| Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | Baseline, Weeks 2 and 6 | — |
| Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Baseline, Weeks 2 and 6 | Blood pressure included supine and sitting systolic and diastolic BP. |
| Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline, Weeks 2 and 6 | — |
| Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline, Weeks 2 and 6 | — |
| Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1 and any day on of Week 1, 2, 4, 6: pre dose (before application of IP) and post dose (after application of IP); Follow up visit (28 days after last dose of study drug = maximum up to Day 71) and Early termination (anytime within week 11) | Local tolerability skin assessments were performed by the investigator and graded based on severity from grade 0 to 4 as: grade 0=none (no evidence of local intolerance); grade 1=mild (minimal erythema and/or oedema, slight glazed appearance); grade 2= moderate (definite erythema and/or oedema with peeling and/or cracking but needs no adaptation of posology) grade 3=severe (erythema, oedema glazing with fissures, few vesicles or papules consider removing topical agent \[if still in place\]) and grade 4= very severe (strong reaction spreading beyond the treated area, bullous reaction, erosions: removal of topical agent \[if still in place\]). Higher grades indicated worsening of condition. Only those categories in which at least 1 participant had data were reported. |
| Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71) | — |
Countries
Australia, Bulgaria, Canada, Denmark, Germany, Hungary, Japan, Latvia, Poland, United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Vehicle Cream Once Daily (QD) Participants or caregivers of participants, topically applied vehicle cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 37 |
| PF-06700841 0.1% Cream QD Participants or caregivers of participants, topically applied PF-06700841 0.1 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 37 |
| PF-06700841 0.3% Cream QD Participants or caregivers of participants, topically applied PF-06700841 0.3 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 36 |
| PF-06700841 1.0% Cream QD Participants or caregivers of participants, topically applied PF-06700841 1.0 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 37 |
| PF-06700841 3.0% Cream QD Participants or caregivers of participants, topically applied PF-06700841 3.0 % cream on all eligible AD areas (of participants) once daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 36 |
| Vehicle Cream Twice Daily (BID) Participants or caregivers of participants, topically applied vehicle cream on all eligible AD areas (of participants) twice daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 36 |
| PF-06700841 0.3% Cream BID Participants or caregivers of participants, topically applied PF-06700841 0.3% cream on all eligible AD areas (of participants) twice daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 36 |
| PF-06700841 1.0% Cream BID Participants or caregivers of participants, topically applied PF-06700841 1.0 % cream on all eligible AD areas (of participants) twice daily for a maximum of 6 weeks. Eligibility of AD areas to be treated were determined on Day 1 by investigator. Participants were followed up for 4 weeks after last dose. | 37 |
| Total | 292 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 | FG003 | FG004 | FG005 | FG006 | FG007 |
|---|---|---|---|---|---|---|---|---|---|
| Follow up Phase (4 Weeks) | Adverse Event | 3 | 2 | 1 | 1 | 0 | 5 | 1 | 0 |
| Follow up Phase (4 Weeks) | Lack of Efficacy | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Follow up Phase (4 Weeks) | Lost to Follow-up | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 3 |
| Follow up Phase (4 Weeks) | Other | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Follow up Phase (4 Weeks) | Pregnancy | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Follow up Phase (4 Weeks) | Refused Further Study Procedures | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Follow up Phase (4 Weeks) | Withdrawal by Subject | 2 | 5 | 3 | 2 | 2 | 2 | 3 | 3 |
| Treatment Phase (6 Weeks) | Adverse Event | 3 | 3 | 1 | 1 | 1 | 6 | 1 | 0 |
| Treatment Phase (6 Weeks) | Lack of Efficacy | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
| Treatment Phase (6 Weeks) | Lost to Follow-up | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Treatment Phase (6 Weeks) | Other | 2 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
| Treatment Phase (6 Weeks) | Physician Decision | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Treatment Phase (6 Weeks) | Pregnancy | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Treatment Phase (6 Weeks) | Protocol Violation | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Treatment Phase (6 Weeks) | Refused Further Treatment | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Treatment Phase (6 Weeks) | Withdrawal by Subject | 2 | 4 | 2 | 2 | 1 | 2 | 3 | 3 |
Baseline characteristics
| Characteristic | Vehicle Cream Once Daily (QD) | PF-06700841 0.1% Cream QD | PF-06700841 0.3% Cream QD | PF-06700841 1.0% Cream QD | PF-06700841 3.0% Cream QD | Vehicle Cream Twice Daily (BID) | PF-06700841 0.3% Cream BID | PF-06700841 1.0% Cream BID | Total |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | 39.1 Years STANDARD_DEVIATION 16.8 | 40.8 Years STANDARD_DEVIATION 15.35 | 43.4 Years STANDARD_DEVIATION 16.43 | 38.4 Years STANDARD_DEVIATION 12.9 | 40.5 Years STANDARD_DEVIATION 12.3 | 42.3 Years STANDARD_DEVIATION 18.18 | 39.4 Years STANDARD_DEVIATION 17.27 | 38.1 Years STANDARD_DEVIATION 15.34 | 40.2 Years STANDARD_DEVIATION 15.59 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants | 0 Participants | 3 Participants | 2 Participants | 1 Participants | 3 Participants | 0 Participants | 4 Participants | 13 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 37 Participants | 37 Participants | 32 Participants | 35 Participants | 35 Participants | 33 Participants | 35 Participants | 33 Participants | 277 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 1 Participants | 0 Participants | 0 Participants | 0 Participants | 1 Participants | 0 Participants | 2 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 4 Participants | 8 Participants | 4 Participants | 8 Participants | 10 Participants | 9 Participants | 9 Participants | 7 Participants | 59 Participants |
| Race (NIH/OMB) Black or African American | 8 Participants | 7 Participants | 9 Participants | 6 Participants | 4 Participants | 6 Participants | 5 Participants | 6 Participants | 51 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 2 Participants | 2 Participants | 1 Participants | 0 Participants | 0 Participants | 0 Participants | 5 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 1 Participants | 0 Participants | 1 Participants | 0 Participants | 0 Participants | 2 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 1 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 1 Participants |
| Race (NIH/OMB) White | 24 Participants | 22 Participants | 21 Participants | 20 Participants | 21 Participants | 20 Participants | 22 Participants | 24 Participants | 174 Participants |
| Sex: Female, Male Female | 20 Participants | 19 Participants | 24 Participants | 23 Participants | 15 Participants | 19 Participants | 16 Participants | 20 Participants | 156 Participants |
| Sex: Female, Male Male | 17 Participants | 18 Participants | 12 Participants | 14 Participants | 21 Participants | 17 Participants | 20 Participants | 17 Participants | 136 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk | EG004 affected / at risk | EG005 affected / at risk | EG006 affected / at risk | EG007 affected / at risk |
|---|---|---|---|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 37 | 0 / 37 | 0 / 36 | 0 / 37 | 0 / 36 | 0 / 36 | 0 / 36 | 0 / 37 |
| other Total, other adverse events | 18 / 37 | 17 / 37 | 11 / 36 | 12 / 37 | 10 / 36 | 17 / 36 | 9 / 36 | 14 / 37 |
| serious Total, serious adverse events | 0 / 37 | 0 / 37 | 0 / 36 | 0 / 37 | 0 / 36 | 0 / 36 | 0 / 36 | 0 / 37 |
Outcome results
Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation
EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.
Time frame: Baseline, Week 6
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Missing data were imputed with multiple imputation method assuming responses are similar to the corresponding vehicle arm under the MAR assumption
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -44.4 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -58.3 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -64.6 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -70.1 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -67.9 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -47.6 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -58.6 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -75.0 Percent change |
Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | 0.4 Units per liter | Standard Deviation 25.99 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -12.3 Units per liter | Standard Deviation 24.82 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -8.8 Units per liter | Standard Deviation 18.25 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -8.6 Units per liter | Standard Deviation 23.93 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -8.8 Units per liter | Standard Deviation 21.56 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -7.8 Units per liter | Standard Deviation 27.99 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -8.1 Units per liter | Standard Deviation 32.02 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -12.0 Units per liter | Standard Deviation 28.83 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -5.4 Units per liter | Standard Deviation 22.87 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -7.4 Units per liter | Standard Deviation 30.2 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -1.9 Units per liter | Standard Deviation 18.18 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | 4.0 Units per liter | Standard Deviation 43.45 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -5.3 Units per liter | Standard Deviation 16.99 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -1.5 Units per liter | Standard Deviation 32.42 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -9.3 Units per liter | Standard Deviation 19.61 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -12.1 Units per liter | Standard Deviation 28.54 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -2.7 Units per liter | Standard Deviation 26.27 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -9.3 Units per liter | Standard Deviation 22.65 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -8.8 Units per liter | Standard Deviation 23.7 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -6.4 Units per liter | Standard Deviation 28.53 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -16.3 Units per liter | Standard Deviation 33.97 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -18.4 Units per liter | Standard Deviation 33.42 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -15.8 Units per liter | Standard Deviation 42.19 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -18.2 Units per liter | Standard Deviation 33.86 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -15.1 Units per liter | Standard Deviation 38.23 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -1.0 Units per liter | Standard Deviation 29.29 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -9.7 Units per liter | Standard Deviation 20.68 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.3 Units per liter | Standard Deviation 22.81 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -8.0 Units per liter | Standard Deviation 34.51 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -11.3 Units per liter | Standard Deviation 29.39 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -19.5 Units per liter | Standard Deviation 19.94 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -8.0 Units per liter | Standard Deviation 19.37 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -8.0 Units per liter | Standard Deviation 22.31 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -13.3 Units per liter | Standard Deviation 25.37 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -11.2 Units per liter | Standard Deviation 22.34 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | 0.2 Units per liter | Standard Deviation 16.48 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -7.0 Units per liter | Standard Deviation 24.65 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -4.3 Units per liter | Standard Deviation 29.08 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -3.7 Units per liter | Standard Deviation 24.96 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry-Lactate Dehydrogenase Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -4.9 Units per liter | Standard Deviation 24.49 |
Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | -0.07 Gram per deciliter | Standard Deviation 0.341 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | -0.13 Gram per deciliter | Standard Deviation 0.403 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | -0.06 Gram per deciliter | Standard Deviation 0.247 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.08 Gram per deciliter | Standard Deviation 0.259 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | -0.09 Gram per deciliter | Standard Deviation 0.383 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.01 Gram per deciliter | Standard Deviation 0.439 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | -0.08 Gram per deciliter | Standard Deviation 0.245 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | -0.06 Gram per deciliter | Standard Deviation 0.235 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | -0.04 Gram per deciliter | Standard Deviation 0.269 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | -0.10 Gram per deciliter | Standard Deviation 0.38 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.04 Gram per deciliter | Standard Deviation 0.294 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | 0.13 Gram per deciliter | Standard Deviation 0.379 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | 0.05 Gram per deciliter | Standard Deviation 0.457 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | 0.10 Gram per deciliter | Standard Deviation 0.26 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | 0.02 Gram per deciliter | Standard Deviation 0.201 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | 0.08 Gram per deciliter | Standard Deviation 0.245 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | 0.07 Gram per deciliter | Standard Deviation 0.315 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | 0.07 Gram per deciliter | Standard Deviation 0.172 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | -0.05 Gram per deciliter | Standard Deviation 0.205 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | 0.03 Gram per deciliter | Standard Deviation 0.303 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | -0.18 Gram per deciliter | Standard Deviation 0.402 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.14 Gram per deciliter | Standard Deviation 0.433 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | -0.08 Gram per deciliter | Standard Deviation 0.429 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | -0.19 Gram per deciliter | Standard Deviation 0.452 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | -0.15 Gram per deciliter | Standard Deviation 0.481 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | -0.10 Gram per deciliter | Standard Deviation 0.283 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | -0.10 Gram per deciliter | Standard Deviation 0.256 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | -0.08 Gram per deciliter | Standard Deviation 0.285 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.14 Gram per deciliter | Standard Deviation 0.333 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | -0.09 Gram per deciliter | Standard Deviation 0.277 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | -0.04 Gram per deciliter | Standard Deviation 0.404 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.02 Gram per deciliter | Standard Deviation 0.269 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | -0.04 Gram per deciliter | Standard Deviation 0.295 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | -0.02 Gram per deciliter | Standard Deviation 0.177 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | -0.02 Gram per deciliter | Standard Deviation 0.204 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | 0.01 Gram per deciliter | Standard Deviation 0.368 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.04 Gram per deciliter | Standard Deviation 0.264 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | 0.01 Gram per deciliter | Standard Deviation 0.239 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | -0.03 Gram per deciliter | Standard Deviation 0.341 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | -0.01 Gram per deciliter | Standard Deviation 0.275 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | 0.01 Gram per deciliter | Standard Deviation 0.561 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | -0.01 Gram per deciliter | Standard Deviation 0.283 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | 0.03 Gram per deciliter | Standard Deviation 0.481 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | -0.03 Gram per deciliter | Standard Deviation 0.405 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.03 Gram per deciliter | Standard Deviation 0.421 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.00 Gram per deciliter | Standard Deviation 0.218 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | 0.00 Gram per deciliter | Standard Deviation 0.256 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | -0.04 Gram per deciliter | Standard Deviation 0.465 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | 0.04 Gram per deciliter | Standard Deviation 0.292 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | -0.01 Gram per deciliter | Standard Deviation 0.346 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | -0.10 Gram per deciliter | Standard Deviation 0.424 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | -0.18 Gram per deciliter | Standard Deviation 0.471 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | -0.05 Gram per deciliter | Standard Deviation 0.218 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | 0.02 Gram per deciliter | Standard Deviation 0.503 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | 0.02 Gram per deciliter | Standard Deviation 0.266 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | -0.09 Gram per deciliter | Standard Deviation 0.262 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | -0.10 Gram per deciliter | Standard Deviation 0.232 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.10 Gram per deciliter | Standard Deviation 0.36 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.03 Gram per deciliter | Standard Deviation 0.252 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | -0.18 Gram per deciliter | Standard Deviation 0.292 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | -0.03 Gram per deciliter | Standard Deviation 0.246 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | -0.09 Gram per deciliter | Standard Deviation 0.398 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | -0.08 Gram per deciliter | Standard Deviation 0.18 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.01 Gram per deciliter | Standard Deviation 0.344 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | -0.02 Gram per deciliter | Standard Deviation 0.211 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | -0.04 Gram per deciliter | Standard Deviation 0.286 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.07 Gram per deciliter | Standard Deviation 0.244 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | -0.15 Gram per deciliter | Standard Deviation 0.242 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | -0.03 Gram per deciliter | Standard Deviation 0.174 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | -0.09 Gram per deciliter | Standard Deviation 0.368 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 1 | 0.00 Gram per deciliter | Standard Deviation 0.169 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 6 | -0.05 Gram per deciliter | Standard Deviation 0.227 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at follow-up visit | 0.02 Gram per deciliter | Standard Deviation 0.299 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at week 4 | 0.03 Gram per deciliter | Standard Deviation 0.224 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 4 | 0.03 Gram per deciliter | Standard Deviation 0.28 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin: change at follow-up visit | 0.06 Gram per deciliter | Standard Deviation 0.181 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 1 | -0.02 Gram per deciliter | Standard Deviation 0.301 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Albumin:change at week 2 | -0.06 Gram per deciliter | Standard Deviation 0.202 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein:change at week 2 | -0.10 Gram per deciliter | Standard Deviation 0.299 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Protein and Albumin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Protein: change at week 6 | -0.09 Gram per deciliter | Standard Deviation 0.31 |
Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | 0.01 Milliequivalents per liter | Standard Deviation 0.389 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | 0.13 Milliequivalents per liter | Standard Deviation 2.548 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | -0.00 Milliequivalents per liter | Standard Deviation 0.363 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | 0.6 Milliequivalents per liter | Standard Deviation 2.97 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | 0.52 Milliequivalents per liter | Standard Deviation 2.56 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | -0.8 Milliequivalents per liter | Standard Deviation 2.31 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | -0.14 Milliequivalents per liter | Standard Deviation 0.367 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | -0.02 Milliequivalents per liter | Standard Deviation 2.916 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | -0.09 Milliequivalents per liter | Standard Deviation 0.373 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | 0.21 Milliequivalents per liter | Standard Deviation 2.739 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | -0.6 Milliequivalents per liter | Standard Deviation 1.98 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | 0.1 Milliequivalents per liter | Standard Deviation 2.34 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | 0.3 Milliequivalents per liter | Standard Deviation 2.05 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | -0.4 Milliequivalents per liter | Standard Deviation 3.26 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | 0.08 Milliequivalents per liter | Standard Deviation 2.229 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.3 Milliequivalents per liter | Standard Deviation 2.7 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.5 Milliequivalents per liter | Standard Deviation 2.23 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | -0.2 Milliequivalents per liter | Standard Deviation 2.52 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | -0.11 Milliequivalents per liter | Standard Deviation 0.379 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.1 Milliequivalents per liter | Standard Deviation 2.11 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | -0.38 Milliequivalents per liter | Standard Deviation 1.759 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.08 Milliequivalents per liter | Standard Deviation 0.282 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | 0.04 Milliequivalents per liter | Standard Deviation 0.298 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.3 Milliequivalents per liter | Standard Deviation 1.89 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | -0.0 Milliequivalents per liter | Standard Deviation 1.77 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | -0.44 Milliequivalents per liter | Standard Deviation 2.598 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | 0.05 Milliequivalents per liter | Standard Deviation 2.128 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | -0.40 Milliequivalents per liter | Standard Deviation 2.151 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | 0.6 Milliequivalents per liter | Standard Deviation 1.83 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 0.66 Milliequivalents per liter | Standard Deviation 2.209 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | -0.06 Milliequivalents per liter | Standard Deviation 0.285 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | -0.3 Milliequivalents per liter | Standard Deviation 2.16 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | 0.03 Milliequivalents per liter | Standard Deviation 0.295 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | 0.0 Milliequivalents per liter | Standard Deviation 2.39 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | 0.1 Milliequivalents per liter | Standard Deviation 2.27 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | 0.6 Milliequivalents per liter | Standard Deviation 1.89 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | 0.5 Milliequivalents per liter | Standard Deviation 2.5 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | 0.10 Milliequivalents per liter | Standard Deviation 0.375 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | -0.2 Milliequivalents per liter | Standard Deviation 2.08 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.3 Milliequivalents per liter | Standard Deviation 1.86 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | 0.66 Milliequivalents per liter | Standard Deviation 2.132 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | -0.7 Milliequivalents per liter | Standard Deviation 2.04 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.1 Milliequivalents per liter | Standard Deviation 2.39 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.2 Milliequivalents per liter | Standard Deviation 2.44 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | -0.2 Milliequivalents per liter | Standard Deviation 2.23 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | -0.1 Milliequivalents per liter | Standard Deviation 2.45 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.03 Milliequivalents per liter | Standard Deviation 0.372 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | -0.07 Milliequivalents per liter | Standard Deviation 0.338 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.3 Milliequivalents per liter | Standard Deviation 1.57 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | 0.7 Milliequivalents per liter | Standard Deviation 2.03 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | 0.2 Milliequivalents per liter | Standard Deviation 2.68 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | -0.02 Milliequivalents per liter | Standard Deviation 0.35 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | 0.0 Milliequivalents per liter | Standard Deviation 2.34 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | -0.20 Milliequivalents per liter | Standard Deviation 1.965 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | -0.06 Milliequivalents per liter | Standard Deviation 0.332 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | 0.8 Milliequivalents per liter | Standard Deviation 2.64 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | -0.51 Milliequivalents per liter | Standard Deviation 1.956 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | -0.24 Milliequivalents per liter | Standard Deviation 2.484 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | 0.03 Milliequivalents per liter | Standard Deviation 0.394 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 0.41 Milliequivalents per liter | Standard Deviation 2.056 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | 0.1 Milliequivalents per liter | Standard Deviation 2.41 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.2 Milliequivalents per liter | Standard Deviation 2.18 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | 0.2 Milliequivalents per liter | Standard Deviation 2.5 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.02 Milliequivalents per liter | Standard Deviation 0.347 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | -0.18 Milliequivalents per liter | Standard Deviation 1.768 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | -0.01 Milliequivalents per liter | Standard Deviation 0.327 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | -0.3 Milliequivalents per liter | Standard Deviation 2.41 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | 0.04 Milliequivalents per liter | Standard Deviation 0.359 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | -0.5 Milliequivalents per liter | Standard Deviation 2.44 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | 0.27 Milliequivalents per liter | Standard Deviation 2.204 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | -0.6 Milliequivalents per liter | Standard Deviation 2.17 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | 0.03 Milliequivalents per liter | Standard Deviation 0.407 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 0.75 Milliequivalents per liter | Standard Deviation 2.386 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | 0.34 Milliequivalents per liter | Standard Deviation 1.868 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | 0.04 Milliequivalents per liter | Standard Deviation 0.351 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | -0.9 Milliequivalents per liter | Standard Deviation 2.4 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | -0.4 Milliequivalents per liter | Standard Deviation 2.23 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | 0.10 Milliequivalents per liter | Standard Deviation 2.129 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.0 Milliequivalents per liter | Standard Deviation 2.54 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.7 Milliequivalents per liter | Standard Deviation 2.71 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | 0.12 Milliequivalents per liter | Standard Deviation 2.407 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | -0.4 Milliequivalents per liter | Standard Deviation 2.9 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | 0.28 Milliequivalents per liter | Standard Deviation 1.638 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | -0.06 Milliequivalents per liter | Standard Deviation 0.262 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | -0.2 Milliequivalents per liter | Standard Deviation 2.87 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.0 Milliequivalents per liter | Standard Deviation 2.66 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.07 Milliequivalents per liter | Standard Deviation 0.343 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | 0.12 Milliequivalents per liter | Standard Deviation 0.358 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | -0.3 Milliequivalents per liter | Standard Deviation 2.16 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.4 Milliequivalents per liter | Standard Deviation 3.08 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.4 Milliequivalents per liter | Standard Deviation 3.61 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | 0.02 Milliequivalents per liter | Standard Deviation 2.011 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | -0.9 Milliequivalents per liter | Standard Deviation 3.55 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | -0.4 Milliequivalents per liter | Standard Deviation 3.5 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | -0.4 Milliequivalents per liter | Standard Deviation 3.05 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | 0.05 Milliequivalents per liter | Standard Deviation 0.375 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | 0.07 Milliequivalents per liter | Standard Deviation 0.346 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | -0.13 Milliequivalents per liter | Standard Deviation 1.931 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | -0.8 Milliequivalents per liter | Standard Deviation 3.59 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 0.43 Milliequivalents per liter | Standard Deviation 2.162 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | 0.7 Milliequivalents per liter | Standard Deviation 1.94 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.6 Milliequivalents per liter | Standard Deviation 2.11 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | 0.63 Milliequivalents per liter | Standard Deviation 2.096 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | 0.4 Milliequivalents per liter | Standard Deviation 2.7 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | 0.3 Milliequivalents per liter | Standard Deviation 3.28 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | 0.9 Milliequivalents per liter | Standard Deviation 2.5 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | -0.09 Milliequivalents per liter | Standard Deviation 0.3 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | 0.5 Milliequivalents per liter | Standard Deviation 2.93 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.4 Milliequivalents per liter | Standard Deviation 2.72 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | 0.09 Milliequivalents per liter | Standard Deviation 2.209 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | -0.06 Milliequivalents per liter | Standard Deviation 0.309 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | 1.3 Milliequivalents per liter | Standard Deviation 2.11 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.01 Milliequivalents per liter | Standard Deviation 0.337 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | -0.15 Milliequivalents per liter | Standard Deviation 2.341 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.2 Milliequivalents per liter | Standard Deviation 2.61 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 0.08 Milliequivalents per liter | Standard Deviation 1.643 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | 0.14 Milliequivalents per liter | Standard Deviation 1.286 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | 0.4 Milliequivalents per liter | Standard Deviation 1.97 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | 0.05 Milliequivalents per liter | Standard Deviation 0.293 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | 0.00 Milliequivalents per liter | Standard Deviation 0.245 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | 0.0 Milliequivalents per liter | Standard Deviation 2.08 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | -0.1 Milliequivalents per liter | Standard Deviation 2.46 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 0.18 Milliequivalents per liter | Standard Deviation 2.3 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | -0.19 Milliequivalents per liter | Standard Deviation 2.038 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | -0.1 Milliequivalents per liter | Standard Deviation 2.23 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | -0.03 Milliequivalents per liter | Standard Deviation 0.415 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | -0.09 Milliequivalents per liter | Standard Deviation 0.475 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | -0.60 Milliequivalents per liter | Standard Deviation 2.354 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.00 Milliequivalents per liter | Standard Deviation 0.429 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.5 Milliequivalents per liter | Standard Deviation 2.02 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | -0.00 Milliequivalents per liter | Standard Deviation 2.695 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | -0.21 Milliequivalents per liter | Standard Deviation 2.388 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | -0.10 Milliequivalents per liter | Standard Deviation 0.355 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | 0.9 Milliequivalents per liter | Standard Deviation 2.73 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.1 Milliequivalents per liter | Standard Deviation 1.77 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.5 Milliequivalents per liter | Standard Deviation 2.2 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | 0.4 Milliequivalents per liter | Standard Deviation 2.15 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | 0.3 Milliequivalents per liter | Standard Deviation 2.35 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | 1.0 Milliequivalents per liter | Standard Deviation 2.21 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | -0.16 Milliequivalents per liter | Standard Deviation 0.438 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at follow-up visit | 1.09 Milliequivalents per liter | Standard Deviation 2.049 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 2 | -0.3 Milliequivalents per liter | Standard Deviation 3.45 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 1 | 0.5 Milliequivalents per liter | Standard Deviation 2.83 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 4 | -0.3 Milliequivalents per liter | Standard Deviation 3.28 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 4 | 0.26 Milliequivalents per liter | Standard Deviation 0.35 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 2 | -0.07 Milliequivalents per liter | Standard Deviation 1.828 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium:change at week 2 | -0.02 Milliequivalents per liter | Standard Deviation 0.322 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 6 | -0.20 Milliequivalents per liter | Standard Deviation 2.217 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 4 | 0.02 Milliequivalents per liter | Standard Deviation 1.704 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 4 | -0.2 Milliequivalents per liter | Standard Deviation 2.57 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at week 1 | -0.1 Milliequivalents per liter | Standard Deviation 3.39 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium: change at follow up | 0.1 Milliequivalents per liter | Standard Deviation 3.32 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at follow-up visit | 0.26 Milliequivalents per liter | Standard Deviation 0.46 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 1 | 0.20 Milliequivalents per liter | Standard Deviation 0.464 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Sodium:change at week 6 | -0.5 Milliequivalents per liter | Standard Deviation 2.49 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at week 2 | 0.2 Milliequivalents per liter | Standard Deviation 2.99 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Bicarbonate: change at week 1 | -0.02 Milliequivalents per liter | Standard Deviation 1.651 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Potassium: change at week 6 | 0.09 Milliequivalents per liter | Standard Deviation 0.388 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride: change at follow-up visit | 0.4 Milliequivalents per liter | Standard Deviation 3.16 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Sodium, Potassium, Chloride and Bicarbonate Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Chloride:change at week 6 | 0.0 Milliequivalents per liter | Standard Deviation 2.32 |
Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | -0.08 Microgram per deciliter | Standard Deviation 0.417 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | 0.01 Microgram per deciliter | Standard Deviation 0.419 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | 0.16 Microgram per deciliter | Standard Deviation 0.807 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 0.0 Microgram per deciliter | Standard Deviation 3.17 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 4.5 Microgram per deciliter | Standard Deviation 11.58 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.8 Microgram per deciliter | Standard Deviation 3.89 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | 0.00 Microgram per deciliter | Standard Deviation 0.317 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | -0.04 Microgram per deciliter | Standard Deviation 0.355 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | 0.6 Microgram per deciliter | Standard Deviation 3.39 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 7.3 Microgram per deciliter | Standard Deviation 15.6 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | 0.13 Microgram per deciliter | Standard Deviation 0.728 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 0.9 Microgram per deciliter | Standard Deviation 4.57 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 9.7 Microgram per deciliter | Standard Deviation 23.71 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | -0.04 Microgram per deciliter | Standard Deviation 0.354 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | -0.11 Microgram per deciliter | Standard Deviation 0.721 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 4.9 Microgram per deciliter | Standard Deviation 8.73 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | 0.21 Microgram per deciliter | Standard Deviation 0.497 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | 0.30 Microgram per deciliter | Standard Deviation 0.99 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | 0.7 Microgram per deciliter | Standard Deviation 2.84 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | 3.5 Microgram per deciliter | Standard Deviation 9.19 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | 0.14 Microgram per deciliter | Standard Deviation 0.731 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | 0.01 Microgram per deciliter | Standard Deviation 0.259 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | 0.07 Microgram per deciliter | Standard Deviation 0.984 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | 0.01 Microgram per deciliter | Standard Deviation 0.606 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | -0.33 Microgram per deciliter | Standard Deviation 0.753 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 1.2 Microgram per deciliter | Standard Deviation 17.34 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | -0.3 Microgram per deciliter | Standard Deviation 3.13 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | -0.11 Microgram per deciliter | Standard Deviation 0.655 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 2.2 Microgram per deciliter | Standard Deviation 11.45 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.0 Microgram per deciliter | Standard Deviation 2.71 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 0.6 Microgram per deciliter | Standard Deviation 3.04 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | -0.01 Microgram per deciliter | Standard Deviation 0.345 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 5.7 Microgram per deciliter | Standard Deviation 13.97 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | 0.10 Microgram per deciliter | Standard Deviation 0.303 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | 2.4 Microgram per deciliter | Standard Deviation 17.55 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | 0.11 Microgram per deciliter | Standard Deviation 0.329 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 0.5 Microgram per deciliter | Standard Deviation 12.5 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | 0.00 Microgram per deciliter | Standard Deviation 0.268 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | 0.0 Microgram per deciliter | Standard Deviation 3.04 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | -0.2 Microgram per deciliter | Standard Deviation 3.11 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | -1.7 Microgram per deciliter | Standard Deviation 10.62 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 0.1 Microgram per deciliter | Standard Deviation 3.12 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.6 Microgram per deciliter | Standard Deviation 3.54 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | -0.02 Microgram per deciliter | Standard Deviation 0.831 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | -0.0 Microgram per deciliter | Standard Deviation 2.67 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | -0.6 Microgram per deciliter | Standard Deviation 3.61 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | 0.05 Microgram per deciliter | Standard Deviation 0.763 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 0.4 Microgram per deciliter | Standard Deviation 2.6 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | -0.06 Microgram per deciliter | Standard Deviation 0.377 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | 0.16 Microgram per deciliter | Standard Deviation 0.678 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | -0.10 Microgram per deciliter | Standard Deviation 0.362 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | 0.12 Microgram per deciliter | Standard Deviation 0.617 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | 0.06 Microgram per deciliter | Standard Deviation 0.756 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | -0.08 Microgram per deciliter | Standard Deviation 0.409 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 3.4 Microgram per deciliter | Standard Deviation 14.62 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 0.6 Microgram per deciliter | Standard Deviation 10.97 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | -1.2 Microgram per deciliter | Standard Deviation 15.86 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | -0.07 Microgram per deciliter | Standard Deviation 0.345 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | -0.21 Microgram per deciliter | Standard Deviation 0.393 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 4.8 Microgram per deciliter | Standard Deviation 13.28 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | -0.03 Microgram per deciliter | Standard Deviation 0.649 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | 2.1 Microgram per deciliter | Standard Deviation 13.8 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | 1.4 Microgram per deciliter | Standard Deviation 3.06 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | 0.00 Microgram per deciliter | Standard Deviation 0.323 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | -0.06 Microgram per deciliter | Standard Deviation 0.621 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.9 Microgram per deciliter | Standard Deviation 3.18 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 1.0 Microgram per deciliter | Standard Deviation 3.19 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | -0.01 Microgram per deciliter | Standard Deviation 0.561 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | 0.03 Microgram per deciliter | Standard Deviation 0.315 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | -0.02 Microgram per deciliter | Standard Deviation 0.248 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | -0.21 Microgram per deciliter | Standard Deviation 0.554 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 4.5 Microgram per deciliter | Standard Deviation 13.99 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | 0.9 Microgram per deciliter | Standard Deviation 3.27 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 4.6 Microgram per deciliter | Standard Deviation 14.77 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | 0.05 Microgram per deciliter | Standard Deviation 0.296 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | 0.05 Microgram per deciliter | Standard Deviation 0.272 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 3.2 Microgram per deciliter | Standard Deviation 12.63 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | 0.06 Microgram per deciliter | Standard Deviation 0.63 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 4.5 Microgram per deciliter | Standard Deviation 8.6 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 1.2 Microgram per deciliter | Standard Deviation 4.22 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | 0.3 Microgram per deciliter | Standard Deviation 3.82 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | 0.07 Microgram per deciliter | Standard Deviation 0.386 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | 0.00 Microgram per deciliter | Standard Deviation 0.739 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 6.0 Microgram per deciliter | Standard Deviation 13.79 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | -0.15 Microgram per deciliter | Standard Deviation 0.842 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | 0.5 Microgram per deciliter | Standard Deviation 3.84 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | -0.14 Microgram per deciliter | Standard Deviation 0.856 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | 0.10 Microgram per deciliter | Standard Deviation 0.441 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 4.4 Microgram per deciliter | Standard Deviation 16.14 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | 0.07 Microgram per deciliter | Standard Deviation 0.423 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 3.1 Microgram per deciliter | Standard Deviation 10 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | -0.02 Microgram per deciliter | Standard Deviation 0.649 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | 0.00 Microgram per deciliter | Standard Deviation 0.376 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 2.8 Microgram per deciliter | Standard Deviation 20.2 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 1.0 Microgram per deciliter | Standard Deviation 3.05 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | 0.00 Microgram per deciliter | Standard Deviation 0.397 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.5 Microgram per deciliter | Standard Deviation 3.63 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | -0.5 Microgram per deciliter | Standard Deviation 9.77 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | -0.02 Microgram per deciliter | Standard Deviation 0.81 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 0.2 Microgram per deciliter | Standard Deviation 2.87 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 0.8 Microgram per deciliter | Standard Deviation 3.78 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 1.3 Microgram per deciliter | Standard Deviation 24.01 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.6 Microgram per deciliter | Standard Deviation 4.19 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 0.2 Microgram per deciliter | Standard Deviation 2.19 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | -0.05 Microgram per deciliter | Standard Deviation 0.419 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | 0.27 Microgram per deciliter | Standard Deviation 1.025 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | -0.08 Microgram per deciliter | Standard Deviation 0.309 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | 0.22 Microgram per deciliter | Standard Deviation 0.806 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | 0.02 Microgram per deciliter | Standard Deviation 0.59 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | 0.05 Microgram per deciliter | Standard Deviation 0.661 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 4.5 Microgram per deciliter | Standard Deviation 29.9 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | 0.06 Microgram per deciliter | Standard Deviation 0.534 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 6.2 Microgram per deciliter | Standard Deviation 16.75 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | -0.7 Microgram per deciliter | Standard Deviation 2.96 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | -3.4 Microgram per deciliter | Standard Deviation 16.37 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | -0.8 Microgram per deciliter | Standard Deviation 3.24 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | -1.9 Microgram per deciliter | Standard Deviation 13.51 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | 0.03 Microgram per deciliter | Standard Deviation 0.389 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | -0.02 Microgram per deciliter | Standard Deviation 0.303 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | -0.05 Microgram per deciliter | Standard Deviation 0.335 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 9.1 Microgram per deciliter | Standard Deviation 17.21 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | 1.3 Microgram per deciliter | Standard Deviation 2.81 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 5.6 Microgram per deciliter | Standard Deviation 13.14 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | 0.4 Microgram per deciliter | Standard Deviation 3.38 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | -0.10 Microgram per deciliter | Standard Deviation 0.293 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | -0.11 Microgram per deciliter | Standard Deviation 0.827 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 7.9 Microgram per deciliter | Standard Deviation 16.67 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | -0.02 Microgram per deciliter | Standard Deviation 0.704 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 0.5 Microgram per deciliter | Standard Deviation 3.42 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | -0.03 Microgram per deciliter | Standard Deviation 0.257 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.8 Microgram per deciliter | Standard Deviation 2.99 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | -0.08 Microgram per deciliter | Standard Deviation 0.677 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | -0.05 Microgram per deciliter | Standard Deviation 0.464 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | -0.01 Microgram per deciliter | Standard Deviation 0.295 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | 0.2 Microgram per deciliter | Standard Deviation 3.52 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | 4.3 Microgram per deciliter | Standard Deviation 12.23 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | -0.21 Microgram per deciliter | Standard Deviation 0.663 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 10.7 Microgram per deciliter | Standard Deviation 26.13 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | -0.03 Microgram per deciliter | Standard Deviation 0.718 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | 0.01 Microgram per deciliter | Standard Deviation 0.378 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 6 | -0.4 Microgram per deciliter | Standard Deviation 3.69 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 1 | -0.1 Microgram per deciliter | Standard Deviation 2.65 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 2 | 2.7 Microgram per deciliter | Standard Deviation 18.07 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at follow- up visit | -0.20 Microgram per deciliter | Standard Deviation 0.989 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate:change at week 1 | -0.14 Microgram per deciliter | Standard Deviation 0.89 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 4 | 3.4 Microgram per deciliter | Standard Deviation 18.33 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose:change at week 1 | 3.3 Microgram per deciliter | Standard Deviation 13.58 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 4 | -0.2 Microgram per deciliter | Standard Deviation 3.61 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 2 | -0.37 Microgram per deciliter | Standard Deviation 1.059 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at week 6 | 1.5 Microgram per deciliter | Standard Deviation 12.62 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 2 | -0.01 Microgram per deciliter | Standard Deviation 0.244 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 4 | 0.10 Microgram per deciliter | Standard Deviation 0.341 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Glucose: change at follow -up visit | 2.0 Microgram per deciliter | Standard Deviation 22.43 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at week 2 | 0.4 Microgram per deciliter | Standard Deviation 3.28 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urea nitrogen: change at follow-up visit | 0.1 Microgram per deciliter | Standard Deviation 3.78 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium:change at week 1 | 0.09 Microgram per deciliter | Standard Deviation 0.318 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 6 | -0.21 Microgram per deciliter | Standard Deviation 1.084 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Urate: change at week 4 | -0.16 Microgram per deciliter | Standard Deviation 0.713 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at follow-up visit | 0.05 Microgram per deciliter | Standard Deviation 0.356 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Clinical Chemistry- Urea Nitrogen, Urate, Calcium and Glucose Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Calcium: change at week 6 | -0.04 Microgram per deciliter | Standard Deviation 0.337 |
Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation
EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.
Time frame: Baseline, Week 6
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Missing data were imputed with multiple imputation method assuming responses are similar to the corresponding vehicle arm under the MAR assumption
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -3.2 Units on a scale |
| PF-06700841 0.1% Cream QD | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -4.5 Units on a scale |
| PF-06700841 0.3% Cream QD | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -4.6 Units on a scale |
| PF-06700841 1.0% Cream QD | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -4.8 Units on a scale |
| PF-06700841 3.0% Cream QD | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -5.5 Units on a scale |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -3.6 Units on a scale |
| PF-06700841 0.3% Cream BID | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -4.4 Units on a scale |
| PF-06700841 1.0% Cream BID | Change From Baseline in Eczema Area and Severity Index (EASI) Total Score at Week 6: Multiple Imputation | -5.3 Units on a scale |
Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6
Time frame: Baseline, Weeks 2 and 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | 0.3 Beats per minute | Standard Deviation 6.19 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 66.8 Beats per minute | Standard Deviation 11.45 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | 0.7 Beats per minute | Standard Deviation 10.05 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | -1.1 Beats per minute | Standard Deviation 7.65 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 66.9 Beats per minute | Standard Deviation 9.33 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | -0.5 Beats per minute | Standard Deviation 8.03 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 68.4 Beats per minute | Standard Deviation 14.66 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | -1.7 Beats per minute | Standard Deviation 9.06 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | -1.8 Beats per minute | Standard Deviation 11.53 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 64.9 Beats per minute | Standard Deviation 9.05 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | -0.6 Beats per minute | Standard Deviation 7.88 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | 0.8 Beats per minute | Standard Deviation 8.53 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | 1.9 Beats per minute | Standard Deviation 8.01 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 64.9 Beats per minute | Standard Deviation 12.26 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | -0.3 Beats per minute | Standard Deviation 8.46 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | 2.2 Beats per minute | Standard Deviation 8.76 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 66.9 Beats per minute | Standard Deviation 12.03 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | -0.8 Beats per minute | Standard Deviation 8.23 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | 1.7 Beats per minute | Standard Deviation 9.13 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 68.2 Beats per minute | Standard Deviation 12.11 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | 0.5 Beats per minute | Standard Deviation 8.76 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Baseline | 68.1 Beats per minute | Standard Deviation 12.48 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 2 | 1.7 Beats per minute | Standard Deviation 12.52 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Electrocardiogram (ECG) Parameter- Heart Rate at Weeks 2 and 6 | Change at week 6 | -0.4 Beats per minute | Standard Deviation 12.06 |
Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | 0.03 10^12*cells per liter | Standard Deviation 0.22 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.04 10^12*cells per liter | Standard Deviation 0.247 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | 0.03 10^12*cells per liter | Standard Deviation 0.261 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.05 10^12*cells per liter | Standard Deviation 0.234 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | 0.0 10^12*cells per liter | Standard Deviation 0.03 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.01 10^12*cells per liter | Standard Deviation 0.216 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | 0.02 10^12*cells per liter | Standard Deviation 0.244 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.05 10^12*cells per liter | Standard Deviation 0.221 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.01 10^12*cells per liter | Standard Deviation 0.18 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.03 10^12*cells per liter | Standard Deviation 0.212 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.07 10^12*cells per liter | Standard Deviation 0.232 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.18 10^12*cells per liter | Standard Deviation 0.251 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.12 10^12*cells per liter | Standard Deviation 0.264 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.16 10^12*cells per liter | Standard Deviation 0.251 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.17 10^12*cells per liter | Standard Deviation 0.265 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | -0.15 10^12*cells per liter | Standard Deviation 0.266 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.10 10^12*cells per liter | Standard Deviation 0.233 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.04 10^12*cells per liter | Standard Deviation 0.238 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | -0.03 10^12*cells per liter | Standard Deviation 0.254 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.04 10^12*cells per liter | Standard Deviation 0.252 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.10 10^12*cells per liter | Standard Deviation 0.208 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | -0.0 10^12*cells per liter | Standard Deviation 0.01 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | 0.01 10^12*cells per liter | Standard Deviation 0.275 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | 0.04 10^12*cells per liter | Standard Deviation 0.3 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.07 10^12*cells per liter | Standard Deviation 0.242 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.08 10^12*cells per liter | Standard Deviation 0.254 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.02 10^12*cells per liter | Standard Deviation 0.262 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.10 10^12*cells per liter | Standard Deviation 0.366 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | -0.0 10^12*cells per liter | Standard Deviation 0.01 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.08 10^12*cells per liter | Standard Deviation 0.298 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | -0.08 10^12*cells per liter | Standard Deviation 0.28 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | -0.0 10^12*cells per liter | Standard Deviation 0.01 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.10 10^12*cells per liter | Standard Deviation 0.256 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.12 10^12*cells per liter | Standard Deviation 0.271 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | 0.0 10^12*cells per liter | Standard Deviation 0.01 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | -0.03 10^12*cells per liter | Standard Deviation 0.308 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.07 10^12*cells per liter | Standard Deviation 0.303 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.08 10^12*cells per liter | Standard Deviation 0.192 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.06 10^12*cells per liter | Standard Deviation 0.229 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.08 10^12*cells per liter | Standard Deviation 0.248 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 1 | -0.09 10^12*cells per liter | Standard Deviation 0.24 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 2 | -0.11 10^12*cells per liter | Standard Deviation 0.232 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 1 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 4 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 6 | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at follow-up visit | 0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes: change at week 2 | -0.0 10^12*cells per liter | Standard Deviation 0.02 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 4 | -0.06 10^12*cells per liter | Standard Deviation 0.219 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at week 6 | -0.08 10^12*cells per liter | Standard Deviation 0.239 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Erythrocytes and Reticulocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Erythrocytes: change at follow-up visit | -0.05 10^12*cells per liter | Standard Deviation 0.262 |
Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | -0.11 Percentage of cells | Standard Deviation 1.801 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | -0.09 Percentage of cells | Standard Deviation 1.39 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | -0.04 Percentage of cells | Standard Deviation 0.36 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | -0.06 Percentage of cells | Standard Deviation 0.431 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | -0.07 Percentage of cells | Standard Deviation 0.272 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | -0.07 Percentage of cells | Standard Deviation 0.485 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | -0.02 Percentage of cells | Standard Deviation 0.304 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | -0.03 Percentage of cells | Standard Deviation 0.382 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -0.12 Percentage of cells | Standard Deviation 7.827 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | 0.57 Percentage of cells | Standard Deviation 7.515 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 1.53 Percentage of cells | Standard Deviation 6.219 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | 0.2 Percentage of cells | Standard Deviation 2.51 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | -0.92 Percentage of cells | Standard Deviation 6.701 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 1.58 Percentage of cells | Standard Deviation 7.591 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -0.5 Percentage of cells | Standard Deviation 2.19 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -1.71 Percentage of cells | Standard Deviation 7.046 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 0.20 Percentage of cells | Standard Deviation 6.175 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | -0.43 Percentage of cells | Standard Deviation 6.772 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | -0.11 Percentage of cells | Standard Deviation 0.396 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | 0.0 Percentage of cells | Standard Deviation 2.45 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | -0.06 Percentage of cells | Standard Deviation 0.382 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | 0.06 Percentage of cells | Standard Deviation 2.105 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -0.6 Percentage of cells | Standard Deviation 2.47 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | 0.95 Percentage of cells | Standard Deviation 8.648 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | 0.06 Percentage of cells | Standard Deviation 2.488 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | -0.51 Percentage of cells | Standard Deviation 2.509 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | 0.04 Percentage of cells | Standard Deviation 2.055 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | 0.3 Percentage of cells | Standard Deviation 2.49 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | 0.02 Percentage of cells | Standard Deviation 1.913 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | 0.16 Percentage of cells | Standard Deviation 1.754 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.03 Percentage of cells | Standard Deviation 0.317 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | -1.42 Percentage of cells | Standard Deviation 8.812 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | -0.03 Percentage of cells | Standard Deviation 1.522 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | 0.42 Percentage of cells | Standard Deviation 1.982 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.16 Percentage of cells | Standard Deviation 0.596 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | 0.12 Percentage of cells | Standard Deviation 1.391 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | -0.8 Percentage of cells | Standard Deviation 1.96 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | -0.15 Percentage of cells | Standard Deviation 0.476 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | -0.58 Percentage of cells | Standard Deviation 7.009 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | 0.02 Percentage of cells | Standard Deviation 0.361 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | 0.11 Percentage of cells | Standard Deviation 0.809 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | -0.12 Percentage of cells | Standard Deviation 1.725 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | 0.06 Percentage of cells | Standard Deviation 0.651 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | -0.22 Percentage of cells | Standard Deviation 1.304 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | -0.24 Percentage of cells | Standard Deviation 1.86 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | 0.01 Percentage of cells | Standard Deviation 0.493 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | -0.08 Percentage of cells | Standard Deviation 0.359 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | 0.33 Percentage of cells | Standard Deviation 2.257 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | 0.17 Percentage of cells | Standard Deviation 1.84 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | -0.95 Percentage of cells | Standard Deviation 6.957 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -0.9 Percentage of cells | Standard Deviation 1.93 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 1.25 Percentage of cells | Standard Deviation 4.974 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | 0.22 Percentage of cells | Standard Deviation 1.57 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -0.65 Percentage of cells | Standard Deviation 6.057 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | -0.02 Percentage of cells | Standard Deviation 0.69 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -0.8 Percentage of cells | Standard Deviation 2.11 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | 0.17 Percentage of cells | Standard Deviation 0.325 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | -0.06 Percentage of cells | Standard Deviation 5.461 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | -0.17 Percentage of cells | Standard Deviation 1.966 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 0.51 Percentage of cells | Standard Deviation 7.297 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.14 Percentage of cells | Standard Deviation 0.378 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 0.84 Percentage of cells | Standard Deviation 7.544 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | -0.31 Percentage of cells | Standard Deviation 1.502 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -0.8 Percentage of cells | Standard Deviation 2.12 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -0.34 Percentage of cells | Standard Deviation 8.219 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | -0.20 Percentage of cells | Standard Deviation 1.298 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 0.68 Percentage of cells | Standard Deviation 5.814 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -0.7 Percentage of cells | Standard Deviation 2.24 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | -0.02 Percentage of cells | Standard Deviation 0.384 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | -0.30 Percentage of cells | Standard Deviation 7.754 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 2.33 Percentage of cells | Standard Deviation 5.616 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | 0.09 Percentage of cells | Standard Deviation 0.413 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.01 Percentage of cells | Standard Deviation 0.46 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -1.3 Percentage of cells | Standard Deviation 2.61 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -1.8 Percentage of cells | Standard Deviation 2.42 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | -1.8 Percentage of cells | Standard Deviation 2.06 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -1.6 Percentage of cells | Standard Deviation 2.64 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -1.4 Percentage of cells | Standard Deviation 3.05 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.02 Percentage of cells | Standard Deviation 0.483 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | -0.06 Percentage of cells | Standard Deviation 0.524 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -1.86 Percentage of cells | Standard Deviation 6.892 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | -0.09 Percentage of cells | Standard Deviation 0.342 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | -0.03 Percentage of cells | Standard Deviation 0.42 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | -0.12 Percentage of cells | Standard Deviation 0.48 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | -0.13 Percentage of cells | Standard Deviation 0.443 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | 0.17 Percentage of cells | Standard Deviation 0.934 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | -0.16 Percentage of cells | Standard Deviation 1.284 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | 0.15 Percentage of cells | Standard Deviation 1.884 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | -0.04 Percentage of cells | Standard Deviation 1.213 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | -0.09 Percentage of cells | Standard Deviation 1.155 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | 0.50 Percentage of cells | Standard Deviation 1.428 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | 0.30 Percentage of cells | Standard Deviation 1.522 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | -0.02 Percentage of cells | Standard Deviation 2.072 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | -0.00 Percentage of cells | Standard Deviation 1.813 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | 0.50 Percentage of cells | Standard Deviation 1.463 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | 0.02 Percentage of cells | Standard Deviation 0.473 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | 0.10 Percentage of cells | Standard Deviation 0.435 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 1.68 Percentage of cells | Standard Deviation 5.208 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 1.43 Percentage of cells | Standard Deviation 5.298 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | 0.82 Percentage of cells | Standard Deviation 6.685 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 1.61 Percentage of cells | Standard Deviation 6.597 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | -2.93 Percentage of cells | Standard Deviation 6.191 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -1.70 Percentage of cells | Standard Deviation 6.037 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | -1.52 Percentage of cells | Standard Deviation 6.661 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | -0.64 Percentage of cells | Standard Deviation 6.833 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | -0.24 Percentage of cells | Standard Deviation 1.217 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -0.7 Percentage of cells | Standard Deviation 2.23 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | -0.10 Percentage of cells | Standard Deviation 1.582 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | -0.13 Percentage of cells | Standard Deviation 1.267 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | 0.06 Percentage of cells | Standard Deviation 8.536 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | -0.06 Percentage of cells | Standard Deviation 1.409 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | -0.41 Percentage of cells | Standard Deviation 2.188 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.19 Percentage of cells | Standard Deviation 0.429 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -0.7 Percentage of cells | Standard Deviation 2.39 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | -0.37 Percentage of cells | Standard Deviation 1.549 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | 0.08 Percentage of cells | Standard Deviation 0.458 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | 0.30 Percentage of cells | Standard Deviation 5.755 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | -0.85 Percentage of cells | Standard Deviation 6.367 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | 1.28 Percentage of cells | Standard Deviation 5.881 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | 1.32 Percentage of cells | Standard Deviation 7.355 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | 0.08 Percentage of cells | Standard Deviation 0.319 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | -1.14 Percentage of cells | Standard Deviation 6.872 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | 0.11 Percentage of cells | Standard Deviation 1.46 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -1.50 Percentage of cells | Standard Deviation 6.578 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -0.4 Percentage of cells | Standard Deviation 2.27 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 0.43 Percentage of cells | Standard Deviation 7.586 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 1.50 Percentage of cells | Standard Deviation 5.639 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | -0.02 Percentage of cells | Standard Deviation 0.473 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | 0.01 Percentage of cells | Standard Deviation 0.402 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -0.9 Percentage of cells | Standard Deviation 2.32 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | -0.37 Percentage of cells | Standard Deviation 1.729 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | 0.02 Percentage of cells | Standard Deviation 0.323 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 0.06 Percentage of cells | Standard Deviation 4.765 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | -0.10 Percentage of cells | Standard Deviation 0.398 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | 0.01 Percentage of cells | Standard Deviation 0.486 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.06 Percentage of cells | Standard Deviation 0.364 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | -0.8 Percentage of cells | Standard Deviation 2.34 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | -0.07 Percentage of cells | Standard Deviation 1.226 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | 0.02 Percentage of cells | Standard Deviation 2.126 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | 0.02 Percentage of cells | Standard Deviation 0.512 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -0.24 Percentage of cells | Standard Deviation 6.146 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | -0.25 Percentage of cells | Standard Deviation 0.541 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -1.32 Percentage of cells | Standard Deviation 6.559 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | -0.31 Percentage of cells | Standard Deviation 1.607 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | -0.27 Percentage of cells | Standard Deviation 1.131 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.11 Percentage of cells | Standard Deviation 0.318 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | -0.35 Percentage of cells | Standard Deviation 1.431 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | -0.15 Percentage of cells | Standard Deviation 1.714 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | 0.12 Percentage of cells | Standard Deviation 1.954 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -0.2 Percentage of cells | Standard Deviation 2.5 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | -0.01 Percentage of cells | Standard Deviation 1.593 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | 0.38 Percentage of cells | Standard Deviation 1.362 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -0.6 Percentage of cells | Standard Deviation 2.51 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | -2.25 Percentage of cells | Standard Deviation 7.468 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | 0.22 Percentage of cells | Standard Deviation 1.323 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | -0.12 Percentage of cells | Standard Deviation 1.03 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | 0.13 Percentage of cells | Standard Deviation 1.205 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | 0.0 Percentage of cells | Standard Deviation 2.73 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | 0.15 Percentage of cells | Standard Deviation 0.399 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | 0.19 Percentage of cells | Standard Deviation 0.443 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | -0.03 Percentage of cells | Standard Deviation 0.298 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -0.7 Percentage of cells | Standard Deviation 2.58 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 1.31 Percentage of cells | Standard Deviation 6.259 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 0.23 Percentage of cells | Standard Deviation 6.175 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 2.41 Percentage of cells | Standard Deviation 6.577 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -0.8 Percentage of cells | Standard Deviation 2.41 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | 1.65 Percentage of cells | Standard Deviation 5.818 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | -1.15 Percentage of cells | Standard Deviation 6.969 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 1.34 Percentage of cells | Standard Deviation 6.165 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.10 Percentage of cells | Standard Deviation 0.409 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | -0.96 Percentage of cells | Standard Deviation 7.843 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | -0.03 Percentage of cells | Standard Deviation 0.532 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | -0.08 Percentage of cells | Standard Deviation 0.712 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | 0.03 Percentage of cells | Standard Deviation 0.515 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | -0.16 Percentage of cells | Standard Deviation 0.557 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | -0.34 Percentage of cells | Standard Deviation 1.258 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | -0.05 Percentage of cells | Standard Deviation 0.362 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 0.59 Percentage of cells | Standard Deviation 5.179 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | 1.65 Percentage of cells | Standard Deviation 6.622 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | -0.56 Percentage of cells | Standard Deviation 5.699 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.03 Percentage of cells | Standard Deviation 0.29 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 0.22 Percentage of cells | Standard Deviation 6.315 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.01 Percentage of cells | Standard Deviation 0.32 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | -0.05 Percentage of cells | Standard Deviation 0.449 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -1.1 Percentage of cells | Standard Deviation 1.98 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 0.50 Percentage of cells | Standard Deviation 5.405 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | 0.11 Percentage of cells | Standard Deviation 1.318 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | 0.50 Percentage of cells | Standard Deviation 4.452 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -0.6 Percentage of cells | Standard Deviation 2.2 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -0.5 Percentage of cells | Standard Deviation 1.97 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | -0.14 Percentage of cells | Standard Deviation 1.199 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | -0.19 Percentage of cells | Standard Deviation 1.043 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | -0.03 Percentage of cells | Standard Deviation 0.291 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | -1.38 Percentage of cells | Standard Deviation 5.415 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -0.49 Percentage of cells | Standard Deviation 6.665 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | 0.03 Percentage of cells | Standard Deviation 0.355 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | -0.15 Percentage of cells | Standard Deviation 0.31 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | -0.01 Percentage of cells | Standard Deviation 1.767 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | -0.10 Percentage of cells | Standard Deviation 0.318 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | -0.05 Percentage of cells | Standard Deviation 2.805 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | -1.0 Percentage of cells | Standard Deviation 2.34 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | 0.14 Percentage of cells | Standard Deviation 1.323 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | 0.13 Percentage of cells | Standard Deviation 0.807 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | -0.17 Percentage of cells | Standard Deviation 5.769 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | -0.09 Percentage of cells | Standard Deviation 0.331 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -0.41 Percentage of cells | Standard Deviation 6.961 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | -0.05 Percentage of cells | Standard Deviation 0.296 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -0.9 Percentage of cells | Standard Deviation 2.55 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | -0.19 Percentage of cells | Standard Deviation 1.41 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | 0.26 Percentage of cells | Standard Deviation 1.543 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | 0.13 Percentage of cells | Standard Deviation 6.029 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | -0.06 Percentage of cells | Standard Deviation 0.624 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | -0.02 Percentage of cells | Standard Deviation 1.324 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | -0.9 Percentage of cells | Standard Deviation 2.29 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | -1.42 Percentage of cells | Standard Deviation 6.498 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | 0.06 Percentage of cells | Standard Deviation 0.315 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | 0.15 Percentage of cells | Standard Deviation 1.599 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | -0.01 Percentage of cells | Standard Deviation 0.411 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | -0.01 Percentage of cells | Standard Deviation 0.355 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -0.7 Percentage of cells | Standard Deviation 2.24 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | 0.05 Percentage of cells | Standard Deviation 1.229 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | 0.40 Percentage of cells | Standard Deviation 1.468 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | -0.19 Percentage of cells | Standard Deviation 0.395 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.04 Percentage of cells | Standard Deviation 0.355 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 0.49 Percentage of cells | Standard Deviation 5.509 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | -0.01 Percentage of cells | Standard Deviation 0.465 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 0.72 Percentage of cells | Standard Deviation 6.638 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -0.9 Percentage of cells | Standard Deviation 2.04 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | 0.16 Percentage of cells | Standard Deviation 1.304 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 1.07 Percentage of cells | Standard Deviation 5.739 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -1.04 Percentage of cells | Standard Deviation 7.376 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | -0.04 Percentage of cells | Standard Deviation 5.3 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.04 Percentage of cells | Standard Deviation 0.446 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | 0.01 Percentage of cells | Standard Deviation 0.472 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | 0.89 Percentage of cells | Standard Deviation 1.85 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 0.07 Percentage of cells | Standard Deviation 5.103 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -0.71 Percentage of cells | Standard Deviation 6.59 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | -1.87 Percentage of cells | Standard Deviation 6.873 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | 0.50 Percentage of cells | Standard Deviation 1.986 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | 0.51 Percentage of cells | Standard Deviation 1.275 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -1.1 Percentage of cells | Standard Deviation 2.84 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -0.6 Percentage of cells | Standard Deviation 2.73 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | 0.22 Percentage of cells | Standard Deviation 1.414 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | -0.12 Percentage of cells | Standard Deviation 0.576 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | -0.03 Percentage of cells | Standard Deviation 1.039 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 4 | -0.5 Percentage of cells | Standard Deviation 2.56 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at follow-up visit | 2.48 Percentage of cells | Standard Deviation 6.914 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 2 | -0.56 Percentage of cells | Standard Deviation 8.017 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 2 | -0.01 Percentage of cells | Standard Deviation 1.755 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 1 | 1.79 Percentage of cells | Standard Deviation 6.269 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 6 | -0.17 Percentage of cells | Standard Deviation 0.75 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes:change at FU visit | 0.11 Percentage of cells | Standard Deviation 0.448 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at follow-up visit | -0.25 Percentage of cells | Standard Deviation 0.572 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at follow-up visit | -0.04 Percentage of cells | Standard Deviation 1.047 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 2 | -0.24 Percentage of cells | Standard Deviation 0.709 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at follow-up visit | -0.13 Percentage of cells | Standard Deviation 2.021 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 1 | -1.44 Percentage of cells | Standard Deviation 6.58 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 2 | -1.0 Percentage of cells | Standard Deviation 2.61 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 6 | -1.01 Percentage of cells | Standard Deviation 8.445 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 6 | 0.01 Percentage of cells | Standard Deviation 0.463 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 4 | -0.37 Percentage of cells | Standard Deviation 1.747 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at week 4 | -0.45 Percentage of cells | Standard Deviation 7.362 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 4 | 0.33 Percentage of cells | Standard Deviation 1.695 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes: change at week 1 | -0.11 Percentage of cells | Standard Deviation 1.251 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 6 | -0.8 Percentage of cells | Standard Deviation 2.6 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 4 | 0.56 Percentage of cells | Standard Deviation 7.264 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 4 | -0.10 Percentage of cells | Standard Deviation 0.464 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes change at week 1 | 0.01 Percentage of cells | Standard Deviation 0.329 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 6 | -0.19 Percentage of cells | Standard Deviation 1.84 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 1 | -0.23 Percentage of cells | Standard Deviation 1.339 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils/Leukocytes: change at follow-up visit | -2.04 Percentage of cells | Standard Deviation 7.7 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 2 | 0.86 Percentage of cells | Standard Deviation 7.264 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at follow-up (FU) visit | -0.3 Percentage of cells | Standard Deviation 2.78 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes/Leukocytes: change at week 6 | 1.52 Percentage of cells | Standard Deviation 7.266 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 4 | 0.05 Percentage of cells | Standard Deviation 0.374 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes/Leukocytes : change at week 6 | -0.16 Percentage of cells | Standard Deviation 1.516 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Reticulocytes/Erythrocytes: change at week 2 | -0.01 Percentage of cells | Standard Deviation 0.389 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils/Leukocytes: change at week 1 | -0.01 Percentage of cells | Standard Deviation 0.57 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils/Leukocytes: change at week 2 | -0.05 Percentage of cells | Standard Deviation 1.531 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology - Hematocrit, Reticulocytes/Erythrocytes, Lymphocytes/Leukocytes, Neutrophils/Leukocytes, Basophils/Leukocytes, Eosinophils/Leukocytes and Monocytes/Leukocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Hematocrit: change at week 1 | -0.9 Percentage of cells | Standard Deviation 2.3 |
Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.01 Gram per deciliter | Standard Deviation 0.79 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | 0.05 Gram per deciliter | Standard Deviation 0.613 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.13 Gram per deciliter | Standard Deviation 0.832 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.16 Gram per deciliter | Standard Deviation 0.636 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | 0.03 Gram per deciliter | Standard Deviation 0.725 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -0.04 Gram per deciliter | Standard Deviation 0.717 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.17 Gram per deciliter | Standard Deviation 0.63 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.22 Gram per deciliter | Standard Deviation 0.62 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.06 Gram per deciliter | Standard Deviation 0.614 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.09 Gram per deciliter | Standard Deviation 0.566 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.64 Gram per deciliter | Standard Deviation 0.715 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.48 Gram per deciliter | Standard Deviation 0.767 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.36 Gram per deciliter | Standard Deviation 0.775 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -0.49 Gram per deciliter | Standard Deviation 0.777 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.48 Gram per deciliter | Standard Deviation 0.659 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.25 Gram per deciliter | Standard Deviation 0.628 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -0.09 Gram per deciliter | Standard Deviation 0.784 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.24 Gram per deciliter | Standard Deviation 0.657 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.03 Gram per deciliter | Standard Deviation 0.617 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.12 Gram per deciliter | Standard Deviation 0.678 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.06 Gram per deciliter | Standard Deviation 0.821 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.26 Gram per deciliter | Standard Deviation 0.726 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.22 Gram per deciliter | Standard Deviation 0.798 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.11 Gram per deciliter | Standard Deviation 0.775 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | 0.00 Gram per deciliter | Standard Deviation 0.773 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.27 Gram per deciliter | Standard Deviation 0.789 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.22 Gram per deciliter | Standard Deviation 0.724 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.16 Gram per deciliter | Standard Deviation 0.83 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.19 Gram per deciliter | Standard Deviation 0.698 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -0.27 Gram per deciliter | Standard Deviation 0.756 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.32 Gram per deciliter | Standard Deviation 0.701 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.21 Gram per deciliter | Standard Deviation 0.584 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.25 Gram per deciliter | Standard Deviation 0.625 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -0.12 Gram per deciliter | Standard Deviation 0.826 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.21 Gram per deciliter | Standard Deviation 0.833 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at follow-up visit | -0.18 Gram per deciliter | Standard Deviation 0.74 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 6 | -0.28 Gram per deciliter | Standard Deviation 0.683 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 1 | -0.27 Gram per deciliter | Standard Deviation 0.679 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 4 | -0.20 Gram per deciliter | Standard Deviation 0.658 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Hemoglobin Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Change at week 2 | -0.32 Gram per deciliter | Standard Deviation 0.793 |
Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit
Time frame: Baseline, Weeks 1, 2, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | 0.033 10^9 *cells per liter | Standard Deviation 0.3375 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | -0.066 10^9 *cells per liter | Standard Deviation 1.5744 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | -0.119 10^9 *cells per liter | Standard Deviation 1.5672 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | -0.019 10^9 *cells per liter | Standard Deviation 0.1087 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | 0.112 10^9 *cells per liter | Standard Deviation 1.6282 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | 0.002 10^9 *cells per liter | Standard Deviation 0.0935 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.011 10^9 *cells per liter | Standard Deviation 0.1806 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | -0.008 10^9 *cells per liter | Standard Deviation 0.5539 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.107 10^9 *cells per liter | Standard Deviation 0.4302 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | -0.006 10^9 *cells per liter | Standard Deviation 0.0319 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | 0.032 10^9 *cells per liter | Standard Deviation 0.1813 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | -0.061 10^9 *cells per liter | Standard Deviation 0.5558 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | 0.017 10^9 *cells per liter | Standard Deviation 0.1777 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | 4.9 10^9 *cells per liter | Standard Deviation 35.17 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | 10.5 10^9 *cells per liter | Standard Deviation 36.42 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | -0.035 10^9 *cells per liter | Standard Deviation 0.1904 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | 1.3 10^9 *cells per liter | Standard Deviation 30.48 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | -0.304 10^9 *cells per liter | Standard Deviation 1.6117 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | 0.027 10^9 *cells per liter | Standard Deviation 1.6137 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | -0.004 10^9 *cells per liter | Standard Deviation 0.0265 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | -0.005 10^9 *cells per liter | Standard Deviation 0.0186 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | 0.027 10^9 *cells per liter | Standard Deviation 1.874 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | -0.006 10^9 *cells per liter | Standard Deviation 0.0328 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | -0.006 10^9 *cells per liter | Standard Deviation 0.1509 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | 0.9 10^9 *cells per liter | Standard Deviation 60.03 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | -0.206 10^9 *cells per liter | Standard Deviation 1.8886 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | -0.002 10^9 *cells per liter | Standard Deviation 0.0179 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | 0.134 10^9 *cells per liter | Standard Deviation 0.3256 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | -0.229 10^9 *cells per liter | Standard Deviation 1.3379 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.006 10^9 *cells per liter | Standard Deviation 0.1796 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | -0.203 10^9 *cells per liter | Standard Deviation 1.739 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | 0.007 10^9 *cells per liter | Standard Deviation 0.0964 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | -4.9 10^9 *cells per liter | Standard Deviation 58.16 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | 0.160 10^9 *cells per liter | Standard Deviation 1.7059 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | 0.022 10^9 *cells per liter | Standard Deviation 0.1461 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | 0.205 10^9 *cells per liter | Standard Deviation 0.9185 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | 0.293 10^9 *cells per liter | Standard Deviation 1.5459 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | 0.006 10^9 *cells per liter | Standard Deviation 0.0931 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | 0.479 10^9 *cells per liter | Standard Deviation 1.0939 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.030 10^9 *cells per liter | Standard Deviation 0.0855 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | 7.1 10^9 *cells per liter | Standard Deviation 43.34 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | 0.016 10^9 *cells per liter | Standard Deviation 0.1343 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | 0.029 10^9 *cells per liter | Standard Deviation 0.109 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | 0.066 10^9 *cells per liter | Standard Deviation 1.0672 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | 0.395 10^9 *cells per liter | Standard Deviation 1.094 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | 0.729 10^9 *cells per liter | Standard Deviation 1.3199 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.124 10^9 *cells per liter | Standard Deviation 0.3659 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | 0.004 10^9 *cells per liter | Standard Deviation 0.0445 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.229 10^9 *cells per liter | Standard Deviation 0.3998 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | -0.003 10^9 *cells per liter | Standard Deviation 0.0259 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | 0.004 10^9 *cells per liter | Standard Deviation 0.0261 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | 0.018 10^9 *cells per liter | Standard Deviation 0.112 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | 0.261 10^9 *cells per liter | Standard Deviation 0.8874 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | 10.1 10^9 *cells per liter | Standard Deviation 37.55 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | 0.145 10^9 *cells per liter | Standard Deviation 0.3735 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | 0.017 10^9 *cells per liter | Standard Deviation 0.1069 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | -0.000 10^9 *cells per liter | Standard Deviation 0.0734 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | 0.194 10^9 *cells per liter | Standard Deviation 0.3533 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | 0.009 10^9 *cells per liter | Standard Deviation 0.0489 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | 0.016 10^9 *cells per liter | Standard Deviation 0.3437 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | -3.3 10^9 *cells per liter | Standard Deviation 32.76 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | -0.001 10^9 *cells per liter | Standard Deviation 0.8996 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | 0.459 10^9 *cells per liter | Standard Deviation 1.5567 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | 6.8 10^9 *cells per liter | Standard Deviation 34.08 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | 0.011 10^9 *cells per liter | Standard Deviation 0.0404 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | 0.030 10^9 *cells per liter | Standard Deviation 0.1212 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | 0.036 10^9 *cells per liter | Standard Deviation 0.0963 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | 0.441 10^9 *cells per liter | Standard Deviation 1.2814 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | 16.3 10^9 *cells per liter | Standard Deviation 37.13 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.021 10^9 *cells per liter | Standard Deviation 0.0824 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | -0.177 10^9 *cells per liter | Standard Deviation 1.0805 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | -0.362 10^9 *cells per liter | Standard Deviation 1.3154 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | -0.009 10^9 *cells per liter | Standard Deviation 0.0276 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | -0.114 10^9 *cells per liter | Standard Deviation 1.4545 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | -0.007 10^9 *cells per liter | Standard Deviation 0.0349 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | -6.6 10^9 *cells per liter | Standard Deviation 41.66 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | 0.013 10^9 *cells per liter | Standard Deviation 0.1234 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | -8.5 10^9 *cells per liter | Standard Deviation 30.15 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | -0.003 10^9 *cells per liter | Standard Deviation 0.0724 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | -0.051 10^9 *cells per liter | Standard Deviation 1.2403 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.030 10^9 *cells per liter | Standard Deviation 0.1467 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | -0.288 10^9 *cells per liter | Standard Deviation 1.6842 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.030 10^9 *cells per liter | Standard Deviation 0.0987 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | 0.189 10^9 *cells per liter | Standard Deviation 1.3534 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | -0.023 10^9 *cells per liter | Standard Deviation 0.1196 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | -0.505 10^9 *cells per liter | Standard Deviation 1.6474 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | -0.025 10^9 *cells per liter | Standard Deviation 0.1351 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | -0.048 10^9 *cells per liter | Standard Deviation 2.0206 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | -8.1 10^9 *cells per liter | Standard Deviation 41.92 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.107 10^9 *cells per liter | Standard Deviation 0.313 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | 0.008 10^9 *cells per liter | Standard Deviation 0.1325 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | 0.010 10^9 *cells per liter | Standard Deviation 0.4115 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | -3.3 10^9 *cells per liter | Standard Deviation 32.39 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | -0.023 10^9 *cells per liter | Standard Deviation 0.0809 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.135 10^9 *cells per liter | Standard Deviation 0.44 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | -0.004 10^9 *cells per liter | Standard Deviation 0.1092 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | -0.079 10^9 *cells per liter | Standard Deviation 0.4826 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | 0.065 10^9 *cells per liter | Standard Deviation 0.6042 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | -0.025 10^9 *cells per liter | Standard Deviation 0.1191 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | -0.007 10^9 *cells per liter | Standard Deviation 0.0321 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | -2.4 10^9 *cells per liter | Standard Deviation 37.68 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | -0.012 10^9 *cells per liter | Standard Deviation 0.0313 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | -0.261 10^9 *cells per liter | Standard Deviation 1.3969 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | -0.002 10^9 *cells per liter | Standard Deviation 0.03 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | 0.036 10^9 *cells per liter | Standard Deviation 1.1595 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | 0.237 10^9 *cells per liter | Standard Deviation 1.4501 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | -0.136 10^9 *cells per liter | Standard Deviation 1.0669 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | 0.104 10^9 *cells per liter | Standard Deviation 0.4337 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | -0.005 10^9 *cells per liter | Standard Deviation 0.1021 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | -0.004 10^9 *cells per liter | Standard Deviation 0.181 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | 0.085 10^9 *cells per liter | Standard Deviation 1.3541 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | 0.007 10^9 *cells per liter | Standard Deviation 0.0407 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | -0.094 10^9 *cells per liter | Standard Deviation 1.2877 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.009 10^9 *cells per liter | Standard Deviation 0.0879 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | 0.343 10^9 *cells per liter | Standard Deviation 1.3049 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | -0.022 10^9 *cells per liter | Standard Deviation 0.4419 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | -0.3 10^9 *cells per liter | Standard Deviation 36.27 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | 0.001 10^9 *cells per liter | Standard Deviation 0.0256 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | 0.407 10^9 *cells per liter | Standard Deviation 1.2225 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | -0.014 10^9 *cells per liter | Standard Deviation 0.1055 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.005 10^9 *cells per liter | Standard Deviation 0.0887 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | 0.1 10^9 *cells per liter | Standard Deviation 32.36 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | 0.096 10^9 *cells per liter | Standard Deviation 1.3199 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | 0.319 10^9 *cells per liter | Standard Deviation 1.0276 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | -2.3 10^9 *cells per liter | Standard Deviation 32.7 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | 0.008 10^9 *cells per liter | Standard Deviation 0.0344 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | 0.112 10^9 *cells per liter | Standard Deviation 1.224 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | -0.003 10^9 *cells per liter | Standard Deviation 0.1092 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | 0.009 10^9 *cells per liter | Standard Deviation 0.098 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | 0.010 10^9 *cells per liter | Standard Deviation 0.0258 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | 0.044 10^9 *cells per liter | Standard Deviation 0.4225 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | -0.1 10^9 *cells per liter | Standard Deviation 32.45 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.081 10^9 *cells per liter | Standard Deviation 0.3839 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | 1.0 10^9 *cells per liter | Standard Deviation 25.76 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.012 10^9 *cells per liter | Standard Deviation 0.4596 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | -0.019 10^9 *cells per liter | Standard Deviation 0.1102 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | 0.329 10^9 *cells per liter | Standard Deviation 1.3938 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | -0.011 10^9 *cells per liter | Standard Deviation 0.093 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | 0.001 10^9 *cells per liter | Standard Deviation 0.0197 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | 0.018 10^9 *cells per liter | Standard Deviation 0.1387 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.019 10^9 *cells per liter | Standard Deviation 0.1055 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | 8.5 10^9 *cells per liter | Standard Deviation 41.61 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | 5.0 10^9 *cells per liter | Standard Deviation 31.39 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | -5.9 10^9 *cells per liter | Standard Deviation 37.47 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | -5.2 10^9 *cells per liter | Standard Deviation 38.53 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | 10.2 10^9 *cells per liter | Standard Deviation 47.3 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | 0.259 10^9 *cells per liter | Standard Deviation 1.129 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | -0.116 10^9 *cells per liter | Standard Deviation 1.0364 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | -0.074 10^9 *cells per liter | Standard Deviation 1.0641 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | -0.244 10^9 *cells per liter | Standard Deviation 1.2763 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | 0.123 10^9 *cells per liter | Standard Deviation 0.8496 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.186 10^9 *cells per liter | Standard Deviation 0.384 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | 0.012 10^9 *cells per liter | Standard Deviation 0.4251 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.139 10^9 *cells per liter | Standard Deviation 0.3977 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | 0.068 10^9 *cells per liter | Standard Deviation 0.3168 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | 0.130 10^9 *cells per liter | Standard Deviation 0.4277 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | 0.069 10^9 *cells per liter | Standard Deviation 1.0706 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | -0.109 10^9 *cells per liter | Standard Deviation 0.9653 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | -0.190 10^9 *cells per liter | Standard Deviation 1.0404 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | -0.250 10^9 *cells per liter | Standard Deviation 1.172 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | -0.020 10^9 *cells per liter | Standard Deviation 0.7731 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | 0.003 10^9 *cells per liter | Standard Deviation 0.0361 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | -0.005 10^9 *cells per liter | Standard Deviation 0.0394 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | -0.007 10^9 *cells per liter | Standard Deviation 0.0495 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | -0.015 10^9 *cells per liter | Standard Deviation 0.0415 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | -0.015 10^9 *cells per liter | Standard Deviation 0.0426 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | -0.014 10^9 *cells per liter | Standard Deviation 0.1216 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | -0.029 10^9 *cells per liter | Standard Deviation 0.0915 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | -0.032 10^9 *cells per liter | Standard Deviation 0.104 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | -0.027 10^9 *cells per liter | Standard Deviation 0.1125 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | 0.008 10^9 *cells per liter | Standard Deviation 0.127 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | 0.017 10^9 *cells per liter | Standard Deviation 0.0865 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | 0.009 10^9 *cells per liter | Standard Deviation 0.0986 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | -0.019 10^9 *cells per liter | Standard Deviation 0.0726 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.021 10^9 *cells per liter | Standard Deviation 0.0739 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | 0.004 10^9 *cells per liter | Standard Deviation 0.0847 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | -0.003 10^9 *cells per liter | Standard Deviation 0.3165 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | -4.9 10^9 *cells per liter | Standard Deviation 31.84 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | -0.006 10^9 *cells per liter | Standard Deviation 0.0621 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | -0.004 10^9 *cells per liter | Standard Deviation 0.0188 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.006 10^9 *cells per liter | Standard Deviation 0.0877 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | -0.007 10^9 *cells per liter | Standard Deviation 1.2637 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | -0.001 10^9 *cells per liter | Standard Deviation 0.0255 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.051 10^9 *cells per liter | Standard Deviation 0.3557 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | -0.008 10^9 *cells per liter | Standard Deviation 0.2483 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | 6.6 10^9 *cells per liter | Standard Deviation 33.4 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | -0.012 10^9 *cells per liter | Standard Deviation 0.0832 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | -0.093 10^9 *cells per liter | Standard Deviation 1.234 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | 0.398 10^9 *cells per liter | Standard Deviation 1.5999 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | 4.4 10^9 *cells per liter | Standard Deviation 37.79 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | -0.117 10^9 *cells per liter | Standard Deviation 1.4856 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | -0.269 10^9 *cells per liter | Standard Deviation 1.0761 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | 0.338 10^9 *cells per liter | Standard Deviation 1.3577 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | -0.035 10^9 *cells per liter | Standard Deviation 0.4054 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | -0.007 10^9 *cells per liter | Standard Deviation 0.1025 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | 0.035 10^9 *cells per liter | Standard Deviation 0.0978 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | -0.228 10^9 *cells per liter | Standard Deviation 0.9681 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | -0.005 10^9 *cells per liter | Standard Deviation 0.0269 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | -0.015 10^9 *cells per liter | Standard Deviation 1.1305 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.018 10^9 *cells per liter | Standard Deviation 0.1047 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | 0.001 10^9 *cells per liter | Standard Deviation 0.0191 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | -0.033 10^9 *cells per liter | Standard Deviation 0.3092 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | 0.2 10^9 *cells per liter | Standard Deviation 37.28 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | 0.003 10^9 *cells per liter | Standard Deviation 0.0244 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | 0.013 10^9 *cells per liter | Standard Deviation 0.0983 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | -0.008 10^9 *cells per liter | Standard Deviation 0.1148 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | 0.017 10^9 *cells per liter | Standard Deviation 1.1291 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | -5.2 10^9 *cells per liter | Standard Deviation 40.7 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.039 10^9 *cells per liter | Standard Deviation 0.4169 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | 0.068 10^9 *cells per liter | Standard Deviation 1.2929 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | -0.003 10^9 *cells per liter | Standard Deviation 0.0433 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | -0.005 10^9 *cells per liter | Standard Deviation 0.9958 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | 0.288 10^9 *cells per liter | Standard Deviation 1.7822 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | 0.029 10^9 *cells per liter | Standard Deviation 0.1788 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | -0.001 10^9 *cells per liter | Standard Deviation 0.0337 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | 0.030 10^9 *cells per liter | Standard Deviation 1.3015 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | -0.009 10^9 *cells per liter | Standard Deviation 0.0373 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | 0.050 10^9 *cells per liter | Standard Deviation 0.4699 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | 0.003 10^9 *cells per liter | Standard Deviation 0.1097 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | 0.001 10^9 *cells per liter | Standard Deviation 0.0295 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | 0.027 10^9 *cells per liter | Standard Deviation 0.2455 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.127 10^9 *cells per liter | Standard Deviation 0.263 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | 0.068 10^9 *cells per liter | Standard Deviation 0.0959 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | 0.070 10^9 *cells per liter | Standard Deviation 0.4603 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | 0.022 10^9 *cells per liter | Standard Deviation 0.0762 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.089 10^9 *cells per liter | Standard Deviation 0.432 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | 0.042 10^9 *cells per liter | Standard Deviation 0.1076 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | 0.210 10^9 *cells per liter | Standard Deviation 1.7456 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | -0.048 10^9 *cells per liter | Standard Deviation 1.3823 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | -2.1 10^9 *cells per liter | Standard Deviation 31.94 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | -0.001 10^9 *cells per liter | Standard Deviation 0.0812 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | 0.168 10^9 *cells per liter | Standard Deviation 1.0902 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | 0.048 10^9 *cells per liter | Standard Deviation 0.152 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | 0.422 10^9 *cells per liter | Standard Deviation 1.8986 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | 0.238 10^9 *cells per liter | Standard Deviation 1.4993 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.051 10^9 *cells per liter | Standard Deviation 0.1244 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | 5.8 10^9 *cells per liter | Standard Deviation 48.55 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | 0.049 10^9 *cells per liter | Standard Deviation 0.1471 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | -1.8 10^9 *cells per liter | Standard Deviation 37.05 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | 0.007 10^9 *cells per liter | Standard Deviation 0.1008 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | 0.7 10^9 *cells per liter | Standard Deviation 36.51 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | 0.088 10^9 *cells per liter | Standard Deviation 1.4614 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | 0.002 10^9 *cells per liter | Standard Deviation 0.0299 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | -0.064 10^9 *cells per liter | Standard Deviation 1.2422 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | 7.5 10^9 *cells per liter | Standard Deviation 37.94 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 2 | 0.005 10^9 *cells per liter | Standard Deviation 0.1256 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 1 | -0.251 10^9 *cells per liter | Standard Deviation 2.2421 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 1 | 0.011 10^9 *cells per liter | Standard Deviation 0.1195 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 2 | 0.169 10^9 *cells per liter | Standard Deviation 0.5319 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at follow-up visit | 2.5 10^9 *cells per liter | Standard Deviation 58.75 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 2 | -0.012 10^9 *cells per liter | Standard Deviation 0.0428 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 1 | -0.006 10^9 *cells per liter | Standard Deviation 0.1165 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at follow-up visit | -0.006 10^9 *cells per liter | Standard Deviation 0.1282 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 6 | -0.012 10^9 *cells per liter | Standard Deviation 0.12 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 1 | 0.002 10^9 *cells per liter | Standard Deviation 0.0343 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 2 | 0.025 10^9 *cells per liter | Standard Deviation 0.1496 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 6 | 8.6 10^9 *cells per liter | Standard Deviation 47.85 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 6 | -0.376 10^9 *cells per liter | Standard Deviation 2.1125 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 4 | 0.176 10^9 *cells per liter | Standard Deviation 0.6274 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 4 | 11.0 10^9 *cells per liter | Standard Deviation 46.26 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at follow-up visit | -0.019 10^9 *cells per liter | Standard Deviation 0.0361 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 6 | 0.079 10^9 *cells per liter | Standard Deviation 0.3846 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 2 | -0.190 10^9 *cells per liter | Standard Deviation 2.0749 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Monocytes: change at week 4 | 0.038 10^9 *cells per liter | Standard Deviation 0.1331 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 4 | -0.004 10^9 *cells per liter | Standard Deviation 0.0323 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at follow-up visit | 0.195 10^9 *cells per liter | Standard Deviation 0.4663 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 6 | -0.022 10^9 *cells per liter | Standard Deviation 0.1415 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 6 | -0.347 10^9 *cells per liter | Standard Deviation 2.1442 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 4 | 0.041 10^9 *cells per liter | Standard Deviation 2.1647 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at follow-up visit | -0.562 10^9 *cells per liter | Standard Deviation 2.3227 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at week 4 | -0.012 10^9 *cells per liter | Standard Deviation 0.1499 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 1 | 12.6 10^9 *cells per liter | Standard Deviation 44.08 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at follow-up visit | -0.404 10^9 *cells per liter | Standard Deviation 2.4817 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Neutrophils: change at week 4 | -0.158 10^9 *cells per liter | Standard Deviation 2.0005 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Eosinophils: change at follow-up visit | -0.011 10^9 *cells per liter | Standard Deviation 0.1945 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 2 | -0.006 10^9 *cells per liter | Standard Deviation 2.3428 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Basophils: change at week 6 | -0.015 10^9 *cells per liter | Standard Deviation 0.0383 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Lymphocytes: change at week 1 | 0.223 10^9 *cells per liter | Standard Deviation 0.3849 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Leukocytes: change at week 1 | -0.025 10^9 *cells per liter | Standard Deviation 2.3529 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Hematology- Platelets, Leukocytes, Lymphocytes, Neutrophils, Basophils, Eosinophils and Monocytes Laboratory Values at Weeks 1, 2, 4, 6 and Follow-up Visit | Platelets: change at week 2 | 14.8 10^9 *cells per liter | Standard Deviation 50.99 |
Change From Baseline in Lipids Profile Values at Week 6
Lipid parameters that were assessed: high density lipoprotein (HDL) cholesterol, triglycerides, cholesterol, low density lipoprotein (LDL) cholesterol.
Time frame: Baseline, Week 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | -3.5 Microgram per deciliter | Standard Deviation 16.39 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | -3.4 Microgram per deciliter | Standard Deviation 14.45 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | 3.3 Microgram per deciliter | Standard Deviation 38.84 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | -2.8 Microgram per deciliter | Standard Deviation 6.65 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | -5.6 Microgram per deciliter | Standard Deviation 27.59 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | 0.1 Microgram per deciliter | Standard Deviation 5.34 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | -6.3 Microgram per deciliter | Standard Deviation 25.28 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | -4.2 Microgram per deciliter | Standard Deviation 59.3 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | -12.8 Microgram per deciliter | Standard Deviation 20.53 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | -6.5 Microgram per deciliter | Standard Deviation 37.3 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | -12.1 Microgram per deciliter | Standard Deviation 16.44 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | -1.3 Microgram per deciliter | Standard Deviation 7.74 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | 1.8 Microgram per deciliter | Standard Deviation 60.74 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | 2.7 Microgram per deciliter | Standard Deviation 8.33 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | 2.1 Microgram per deciliter | Standard Deviation 20.13 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | 6.8 Microgram per deciliter | Standard Deviation 24.09 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | -18.9 Microgram per deciliter | Standard Deviation 56.78 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | 1.9 Microgram per deciliter | Standard Deviation 11.18 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | -11.0 Microgram per deciliter | Standard Deviation 29.06 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | -10.4 Microgram per deciliter | Standard Deviation 30.79 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | -0.8 Microgram per deciliter | Standard Deviation 14.48 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | -0.2 Microgram per deciliter | Standard Deviation 18.7 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | 0.0 Microgram per deciliter | Standard Deviation 6.76 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | -8.1 Microgram per deciliter | Standard Deviation 50.41 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | -7.0 Microgram per deciliter | Standard Deviation 58.36 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | 1.2 Microgram per deciliter | Standard Deviation 4.12 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | 5.3 Microgram per deciliter | Standard Deviation 30.58 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | 4.4 Microgram per deciliter | Standard Deviation 23.55 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | HDL cholesterol | 0.3 Microgram per deciliter | Standard Deviation 8.56 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | LDL Cholesterol | -1.1 Microgram per deciliter | Standard Deviation 16.29 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | Triglycerides | -4.4 Microgram per deciliter | Standard Deviation 55.66 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Lipids Profile Values at Week 6 | Cholesterol | -0.9 Microgram per deciliter | Standard Deviation 19.86 |
Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6
Time frame: Baseline, Weeks 2 and 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | -1.4 Milliseconds | Standard Deviation 8.02 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | -4.1 Milliseconds | Standard Deviation 14.61 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 161.9 Milliseconds | Standard Deviation 23.3 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 92.5 Milliseconds | Standard Deviation 9.36 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 407.7 Milliseconds | Standard Deviation 17.78 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | -0.9 Milliseconds | Standard Deviation 10.16 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 395.2 Milliseconds | Standard Deviation 31.53 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | -4.9 Milliseconds | Standard Deviation 19.54 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | -1.9 Milliseconds | Standard Deviation 6.55 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 0.8 Milliseconds | Standard Deviation 14.41 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | -5.7 Milliseconds | Standard Deviation 11.86 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | -5.9 Milliseconds | Standard Deviation 23.16 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 397.9 Milliseconds | Standard Deviation 15.98 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 91.5 Milliseconds | Standard Deviation 9.71 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | -0.4 Milliseconds | Standard Deviation 5.34 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | 1.3 Milliseconds | Standard Deviation 18.11 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 385.3 Milliseconds | Standard Deviation 23.64 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | -0.9 Milliseconds | Standard Deviation 15.92 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | -0.5 Milliseconds | Standard Deviation 14.93 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | 1.4 Milliseconds | Standard Deviation 5.62 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | -0.1 Milliseconds | Standard Deviation 13.81 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | -1.5 Milliseconds | Standard Deviation 13.7 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 160.2 Milliseconds | Standard Deviation 24.01 |
| PF-06700841 0.1% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | -1.3 Milliseconds | Standard Deviation 17.73 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 388.8 Milliseconds | Standard Deviation 33.66 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 403.8 Milliseconds | Standard Deviation 22.43 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | 0.9 Milliseconds | Standard Deviation 16.11 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | -3.9 Milliseconds | Standard Deviation 15.6 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 0.7 Milliseconds | Standard Deviation 18.54 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | -1.1 Milliseconds | Standard Deviation 19.31 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | 2.8 Milliseconds | Standard Deviation 19.66 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 91.1 Milliseconds | Standard Deviation 9.29 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 161.4 Milliseconds | Standard Deviation 27.59 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | -1.3 Milliseconds | Standard Deviation 3.46 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | -1.9 Milliseconds | Standard Deviation 14.37 |
| PF-06700841 0.3% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | -0.5 Milliseconds | Standard Deviation 4.76 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | -0.8 Milliseconds | Standard Deviation 5.64 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 162.5 Milliseconds | Standard Deviation 22.04 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | 0.3 Milliseconds | Standard Deviation 17.19 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 0.3 Milliseconds | Standard Deviation 10.13 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 401.0 Milliseconds | Standard Deviation 25.23 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | 2.9 Milliseconds | Standard Deviation 13.63 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | 3.5 Milliseconds | Standard Deviation 21.06 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 408.5 Milliseconds | Standard Deviation 18.42 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | -0.9 Milliseconds | Standard Deviation 4.04 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | 2.6 Milliseconds | Standard Deviation 16.2 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 93.0 Milliseconds | Standard Deviation 11.13 |
| PF-06700841 1.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | -4.1 Milliseconds | Standard Deviation 23.42 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | -0.6 Milliseconds | Standard Deviation 12.75 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 160.7 Milliseconds | Standard Deviation 24.2 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 1.1 Milliseconds | Standard Deviation 14.42 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | 3.5 Milliseconds | Standard Deviation 21.88 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 93.1 Milliseconds | Standard Deviation 8.69 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | 0.1 Milliseconds | Standard Deviation 4.79 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | -1.3 Milliseconds | Standard Deviation 4 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 401.0 Milliseconds | Standard Deviation 16.29 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | -1.4 Milliseconds | Standard Deviation 14.93 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 392.0 Milliseconds | Standard Deviation 27.36 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | -4.5 Milliseconds | Standard Deviation 15.75 |
| PF-06700841 3.0% Cream QD | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | -0.9 Milliseconds | Standard Deviation 20.12 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | 4.0 Milliseconds | Standard Deviation 14.56 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | 0.9 Milliseconds | Standard Deviation 6.37 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 92.2 Milliseconds | Standard Deviation 13 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 390.9 Milliseconds | Standard Deviation 24.87 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | 7.8 Milliseconds | Standard Deviation 24.11 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 6.0 Milliseconds | Standard Deviation 14.79 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | 1.4 Milliseconds | Standard Deviation 15.56 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | 1.5 Milliseconds | Standard Deviation 9.29 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 156.4 Milliseconds | Standard Deviation 22.65 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | 4.6 Milliseconds | Standard Deviation 14.27 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 403.0 Milliseconds | Standard Deviation 16.65 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | 1.2 Milliseconds | Standard Deviation 24.03 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | 0.6 Milliseconds | Standard Deviation 5.49 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | 2.4 Milliseconds | Standard Deviation 10.32 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | 0.2 Milliseconds | Standard Deviation 8.07 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | 2.0 Milliseconds | Standard Deviation 11.94 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 92.4 Milliseconds | Standard Deviation 13.3 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 383.8 Milliseconds | Standard Deviation 30.79 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | 6.5 Milliseconds | Standard Deviation 19.15 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 1.2 Milliseconds | Standard Deviation 16.06 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | -1.4 Milliseconds | Standard Deviation 20.47 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | -2.3 Milliseconds | Standard Deviation 18.69 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 157.9 Milliseconds | Standard Deviation 23.55 |
| PF-06700841 0.3% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 397.7 Milliseconds | Standard Deviation 17.05 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: baseline | 405.0 Milliseconds | Standard Deviation 20.38 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 6 | -0.2 Milliseconds | Standard Deviation 9.67 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 6 | 0.7 Milliseconds | Standard Deviation 5.67 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 2 | -4.6 Milliseconds | Standard Deviation 25.76 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: baseline | 157.8 Milliseconds | Standard Deviation 23.15 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 6 | 5.7 Milliseconds | Standard Deviation 16.11 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QTCF interval: change at week 2 | -4.6 Milliseconds | Standard Deviation 15.43 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: baseline | 390.6 Milliseconds | Standard Deviation 32.43 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QT interval: change at week 6 | 4.0 Milliseconds | Standard Deviation 27.74 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: baseline | 91.5 Milliseconds | Standard Deviation 11.68 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | PR interval: change at week 2 | 2.1 Milliseconds | Standard Deviation 7.98 |
| PF-06700841 1.0% Cream BID | Change From Baseline in PR, QRS, QTCF and QT Interval at Weeks 2 and 6 | QRS interval: change at week 2 | 1.0 Milliseconds | Standard Deviation 5.63 |
Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6
Mean change in total cholesterol/HDL cholesterol ratio was assessed and reported.
Time frame: Baseline, Week 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | 0.0 Ratio | Standard Deviation 0.31 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | -0.1 Ratio | Standard Deviation 0.48 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | -0.2 Ratio | Standard Deviation 0.4 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | -0.0 Ratio | Standard Deviation 0.32 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | -0.3 Ratio | Standard Deviation 0.77 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | -0.0 Ratio | Standard Deviation 0.35 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | 0.0 Ratio | Standard Deviation 0.46 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Ratio of LDL Cholesterol to HDL Cholesterol Lipids Profile at Week 6 | -0.0 Ratio | Standard Deviation 0.42 |
Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6
Blood pressure included supine and sitting systolic and diastolic BP.
Time frame: Baseline, Weeks 2 and 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 117.7 Millimeters of mercury | Standard Deviation 13.05 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | 0.8 Millimeters of mercury | Standard Deviation 9.9 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | -1.6 Millimeters of mercury | Standard Deviation 8.49 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | -0.2 Millimeters of mercury | Standard Deviation 12.98 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 123.3 Millimeters of mercury | Standard Deviation 12.01 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | 0.6 Millimeters of mercury | Standard Deviation 12.24 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 77.7 Millimeters of mercury | Standard Deviation 9.28 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | 0.5 Millimeters of mercury | Standard Deviation 7.51 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | 0.3 Millimeters of mercury | Standard Deviation 11.55 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | -2.5 Millimeters of mercury | Standard Deviation 7.69 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | 1.3 Millimeters of mercury | Standard Deviation 12.12 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 76.5 Millimeters of mercury | Standard Deviation 9.28 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | 0.6 Millimeters of mercury | Standard Deviation 6.47 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 75.2 Millimeters of mercury | Standard Deviation 8.79 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | 0.0 Millimeters of mercury | Standard Deviation 5.79 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | -1.4 Millimeters of mercury | Standard Deviation 9.61 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | 1.1 Millimeters of mercury | Standard Deviation 10.06 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | 0.7 Millimeters of mercury | Standard Deviation 7.93 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 120.8 Millimeters of mercury | Standard Deviation 10.26 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 123.2 Millimeters of mercury | Standard Deviation 12.35 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 80.1 Millimeters of mercury | Standard Deviation 6.76 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | -1.9 Millimeters of mercury | Standard Deviation 11.86 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | 1.5 Millimeters of mercury | Standard Deviation 7.61 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | -7.5 Millimeters of mercury | Standard Deviation 8.67 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | -1.6 Millimeters of mercury | Standard Deviation 11.97 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | -9.4 Millimeters of mercury | Standard Deviation 8.95 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | -0.7 Millimeters of mercury | Standard Deviation 8.32 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 78.8 Millimeters of mercury | Standard Deviation 8.39 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | 0.0 Millimeters of mercury | Standard Deviation 9.44 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | -0.4 Millimeters of mercury | Standard Deviation 8.5 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | 2.0 Millimeters of mercury | Standard Deviation 14.05 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | 0.5 Millimeters of mercury | Standard Deviation 14.73 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 120.2 Millimeters of mercury | Standard Deviation 12.43 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | -3.9 Millimeters of mercury | Standard Deviation 14.54 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 77.8 Millimeters of mercury | Standard Deviation 10.02 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 123.0 Millimeters of mercury | Standard Deviation 13.89 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 69.6 Millimeters of mercury | Standard Deviation 11.48 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 116.9 Millimeters of mercury | Standard Deviation 17.76 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | 1.0 Millimeters of mercury | Standard Deviation 14.63 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | 2.3 Millimeters of mercury | Standard Deviation 6.99 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 74.5 Millimeters of mercury | Standard Deviation 8.26 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | 1.3 Millimeters of mercury | Standard Deviation 13.59 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | 1.1 Millimeters of mercury | Standard Deviation 15.61 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | 0.5 Millimeters of mercury | Standard Deviation 7.96 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | 0.2 Millimeters of mercury | Standard Deviation 9.13 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 119.7 Millimeters of mercury | Standard Deviation 9.08 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | 1.6 Millimeters of mercury | Standard Deviation 10.33 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | 1.6 Millimeters of mercury | Standard Deviation 12 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | 1.2 Millimeters of mercury | Standard Deviation 8.32 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 122.6 Millimeters of mercury | Standard Deviation 12.76 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | -0.3 Millimeters of mercury | Standard Deviation 10.25 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | -3.4 Millimeters of mercury | Standard Deviation 11.02 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 124.6 Millimeters of mercury | Standard Deviation 11.25 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | -2.4 Millimeters of mercury | Standard Deviation 11.76 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | -8.4 Millimeters of mercury | Standard Deviation 10.81 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 75.9 Millimeters of mercury | Standard Deviation 8.78 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | -0.9 Millimeters of mercury | Standard Deviation 10.65 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 80.9 Millimeters of mercury | Standard Deviation 8.21 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | -2.9 Millimeters of mercury | Standard Deviation 10.77 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | -5.3 Millimeters of mercury | Standard Deviation 9.27 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | -1.4 Millimeters of mercury | Standard Deviation 10.49 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | -0.6 Millimeters of mercury | Standard Deviation 14.4 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 119.4 Millimeters of mercury | Standard Deviation 12.96 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 75.1 Millimeters of mercury | Standard Deviation 5.77 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | -2.8 Millimeters of mercury | Standard Deviation 12.6 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 123.1 Millimeters of mercury | Standard Deviation 12.4 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | -2.8 Millimeters of mercury | Standard Deviation 6.69 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | -3.1 Millimeters of mercury | Standard Deviation 10.46 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | -0.3 Millimeters of mercury | Standard Deviation 8.02 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | -1.6 Millimeters of mercury | Standard Deviation 6.22 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 77.5 Millimeters of mercury | Standard Deviation 8.71 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | 1.7 Millimeters of mercury | Standard Deviation 8.2 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | -3.6 Millimeters of mercury | Standard Deviation 8.37 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | 1.6 Millimeters of mercury | Standard Deviation 8.89 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | 1.1 Millimeters of mercury | Standard Deviation 9.81 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | 1.9 Millimeters of mercury | Standard Deviation 9.72 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 122.9 Millimeters of mercury | Standard Deviation 15.25 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 77.1 Millimeters of mercury | Standard Deviation 12 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | 2.1 Millimeters of mercury | Standard Deviation 12.41 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | 3.5 Millimeters of mercury | Standard Deviation 13.65 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | -0.3 Millimeters of mercury | Standard Deviation 7.89 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | 4.5 Millimeters of mercury | Standard Deviation 5.8 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 117.1 Millimeters of mercury | Standard Deviation 14.07 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 74.4 Millimeters of mercury | Standard Deviation 8.2 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: Baseline | 73.7 Millimeters of mercury | Standard Deviation 8.59 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 6 | 0.5 Millimeters of mercury | Standard Deviation 6.32 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 6 | -1.5 Millimeters of mercury | Standard Deviation 5.8 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 2 | -1.2 Millimeters of mercury | Standard Deviation 6.49 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: change at week 6 | 0.4 Millimeters of mercury | Standard Deviation 8.41 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 6 | 0.6 Millimeters of mercury | Standard Deviation 10.31 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: Baseline | 118.9 Millimeters of mercury | Standard Deviation 12.43 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting diastolic BP: Baseline | 80.3 Millimeters of mercury | Standard Deviation 7.83 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine diastolic BP: change at week 2 | 1.4 Millimeters of mercury | Standard Deviation 7.74 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: Baseline | 125.6 Millimeters of mercury | Standard Deviation 12.21 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Supine systolic BP: change at week 2 | 2.9 Millimeters of mercury | Standard Deviation 8.48 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Blood Pressure (BP) at Weeks 2 and 6 | Sitting systolic BP: change at week 2 | 4.4 Millimeters of mercury | Standard Deviation 11.68 |
Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6
Time frame: Baseline, Weeks 2 and 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 69.6 Beats per minute | Standard Deviation 12.58 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 2.1 Beats per minute | Standard Deviation 10.59 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 0.5 Beats per minute | Standard Deviation 10.41 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 0.3 Beats per minute | Standard Deviation 8.04 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 0.2 Beats per minute | Standard Deviation 8.11 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 69.5 Beats per minute | Standard Deviation 9.82 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | -1.4 Beats per minute | Standard Deviation 11.9 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 72.9 Beats per minute | Standard Deviation 14.3 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | -2.5 Beats per minute | Standard Deviation 9.66 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 67.9 Beats per minute | Standard Deviation 9.31 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 1.1 Beats per minute | Standard Deviation 9.13 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 0.9 Beats per minute | Standard Deviation 9.71 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 0.5 Beats per minute | Standard Deviation 6.54 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 68.8 Beats per minute | Standard Deviation 11.76 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 1.8 Beats per minute | Standard Deviation 8.73 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 3.7 Beats per minute | Standard Deviation 9.47 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 69.4 Beats per minute | Standard Deviation 11.15 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 4.1 Beats per minute | Standard Deviation 6.76 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 2.8 Beats per minute | Standard Deviation 8.28 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 70.1 Beats per minute | Standard Deviation 11.18 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 0.5 Beats per minute | Standard Deviation 9.12 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Baseline | 68.2 Beats per minute | Standard Deviation 9.59 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 2 | 4.1 Beats per minute | Standard Deviation 9.16 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Pulse Rate at Weeks 2 and 6 | Change at week 6 | 1.8 Beats per minute | Standard Deviation 8.64 |
Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6
Time frame: Baseline, Weeks 2 and 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | -0.1 Degree Celsius | Standard Deviation 0.41 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | -0.0 Degree Celsius | Standard Deviation 0.4 |
| Vehicle Cream Once Daily (QD) | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.5 Degree Celsius | Standard Deviation 0.33 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | -0.0 Degree Celsius | Standard Deviation 0.29 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.5 Degree Celsius | Standard Deviation 0.43 |
| PF-06700841 0.1% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | -0.1 Degree Celsius | Standard Deviation 0.3 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.6 Degree Celsius | Standard Deviation 0.44 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | 0.0 Degree Celsius | Standard Deviation 0.38 |
| PF-06700841 0.3% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | 0.0 Degree Celsius | Standard Deviation 0.38 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | -0.0 Degree Celsius | Standard Deviation 0.43 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.6 Degree Celsius | Standard Deviation 0.33 |
| PF-06700841 1.0% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | 0.1 Degree Celsius | Standard Deviation 0.32 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | 0.1 Degree Celsius | Standard Deviation 0.35 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.5 Degree Celsius | Standard Deviation 0.37 |
| PF-06700841 3.0% Cream QD | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | 0.0 Degree Celsius | Standard Deviation 0.29 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | -0.0 Degree Celsius | Standard Deviation 0.38 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.5 Degree Celsius | Standard Deviation 0.29 |
| Vehicle Cream Twice Daily (BID) | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | 0.1 Degree Celsius | Standard Deviation 0.5 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | 0.0 Degree Celsius | Standard Deviation 0.34 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.6 Degree Celsius | Standard Deviation 0.41 |
| PF-06700841 0.3% Cream BID | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | 0.0 Degree Celsius | Standard Deviation 0.37 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Baseline | 36.6 Degree Celsius | Standard Deviation 0.29 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 2 | 0.0 Degree Celsius | Standard Deviation 0.41 |
| PF-06700841 1.0% Cream BID | Change From Baseline in Vital Signs- Temperature at Weeks 2 and 6 | Change at week 6 | -0.0 Degree Celsius | Standard Deviation 0.46 |
Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings
Clinically significant ECG criteria included PR interval: value greater than (\>) 280 millisecond (msec), percentage change greater than equal to (\>=) 25/50 percentage, QRS interval: value \>120 msec, percentage change \>= 50% and QT interval corrected using the Fridericia's formula (QTCF) value 450 msec and 30\<=change\<60.
Time frame: Baseline up to Week 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 2 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 2 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: %Change>=50% | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QRS interval: value >120 msec | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 30<=Change<60 | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | QTCF: 450 msec | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : value >280 msec | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Clinically Significant Change in Electrocardiogram (ECG) Findings | PR interval : %change>=25/50% | 0 Participants |
Number of Participants With Each Severity Grade in Local Tolerability Assessments
Local tolerability skin assessments were performed by the investigator and graded based on severity from grade 0 to 4 as: grade 0=none (no evidence of local intolerance); grade 1=mild (minimal erythema and/or oedema, slight glazed appearance); grade 2= moderate (definite erythema and/or oedema with peeling and/or cracking but needs no adaptation of posology) grade 3=severe (erythema, oedema glazing with fissures, few vesicles or papules consider removing topical agent \[if still in place\]) and grade 4= very severe (strong reaction spreading beyond the treated area, bullous reaction, erosions: removal of topical agent \[if still in place\]). Higher grades indicated worsening of condition. Only those categories in which at least 1 participant had data were reported.
Time frame: Day 1 and any day on of Week 1, 2, 4, 6: pre dose (before application of IP) and post dose (after application of IP); Follow up visit (28 days after last dose of study drug = maximum up to Day 71) and Early termination (anytime within week 11)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 26 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 31 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 22 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 2 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 33 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 28 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 28 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 2 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 24 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 29 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 6 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 2 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 2 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 35 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 3 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 2 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 27 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 25 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 26 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 28 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 25 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 26 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 26 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 36 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 35 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 29 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 3 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 5 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 2 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 26 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 24 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 28 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 3 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 29 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 26 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 3 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 3 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 30 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 3 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 29 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 28 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 31 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 4 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 30 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 30 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 25 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 3 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 28 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 3 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 29 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 2 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 2 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 3 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 30 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 33 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 3 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 29 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 30 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 30 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 3 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 31 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 30 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 2 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 2 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 2 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 25 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 30 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 30 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 2 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 33 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 4 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 29 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 30 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 29 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 30 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 36 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 35 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 30 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 3 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 28 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 2 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 30 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 28 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 29 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 2 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 34 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 22 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 21 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 35 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 9 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 23 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 24 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 24 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 27 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 30 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 2 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 23 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 25 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 3 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 2 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 30 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 32 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 32 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 33 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 4 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 26 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 32 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 31 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 2 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 34 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 30 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 31 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 2 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 31 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: mild | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: none | 33 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: none | 28 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: mild | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: mild | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: none | 33 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: none | 30 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: severe | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: none | 33 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability before: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: none | 31 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 1: tolerability after: none | 31 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: none | 36 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: none | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: severe | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability before: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: mild | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability before: none | 32 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: none | 30 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Day 1: tolerability before: moderate | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Follow Up: tolerability: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability after: mild | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 6: tolerability after: none | 30 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 4: tolerability after: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Week 2: tolerability before: moderate | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Each Severity Grade in Local Tolerability Assessments | Early termination:tolerability: mild | 1 Participants |
Number of Participants With Laboratory Abnormalities
Hemoglobin (HGB),hematocrit,erythrocytes (ery.),HDL cholesterol (chl.)\<0.8\*lower limit of normal(LLN);reticulocytes (ret.), ret./ery. (%)\<0.5\*LLN,\>1.5\*upper limit of normal (ULN);ery. mean corpuscular (EMC) volume,EMC HGB,EMC HGB concentration,potassium,chloride,calcium,bicarbonate\<0.9\*LLN,\>1.1\*ULN;platelets\<0.5\*LLN,\>1.75\*ULN;leukocytes (leu.),glucose\<0.6\*LLN,\>1.5\*ULN;lymphocytes (lym.), lym./leu.(%), neutrophils (neu.), neu./leu. (%), protein,albumin \<0.8\*LLN,\>1.2\*ULN;basophils (bas.), bas./leu.(%), eosinophils (eos.), eos./leu., monocytes (mon.), mon./leu.(%), urate \>1.2\*ULN;bilirubin (total, direct, indirect)\>1.5\*ULN;aspartate/alanine aminotransferase, gamma glutamyl transferase, lactate dehydrogenase, alkaline phosphatase\>3.0\*ULN;urea nitrogen, creatinine, triglycerides, chl.\>1.3\*ULN; sodium \<0.95\*LLN,\>1.05\*ULN; creatine kinase \>2.0\*ULN;Urine: pH\<4.5,\>8;glucose, ketones, protein, HGB, urobilinogen,bilirubin,nitrite,leukocyte esterase\>=1;ery., leu.\>= 20;hyaline casts\>1;bacteria\>20.
Time frame: Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure.
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Vehicle Cream Once Daily (QD) | Number of Participants With Laboratory Abnormalities | 26 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Laboratory Abnormalities | 22 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Laboratory Abnormalities | 23 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Laboratory Abnormalities | 22 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Laboratory Abnormalities | 16 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Laboratory Abnormalities | 21 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Laboratory Abnormalities | 24 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Laboratory Abnormalities | 24 Participants |
Number of Participants With Pre-defined Criteria For Vital Signs
Pre-defined criteria included: 1) Diastolic blood pressure (DBP), a) sitting DBP: change of \>= 20 millimeter of mercury (mmHg) increase, b) sitting DBP: change of \>=20mmHg decrease, c) supine DBP: less than (\<) 50 mmHg, d) supine DBP: change of \>= 20mmHg increase, e) supine DBP: change of \>= 20mmHg decrease; 2) Systolic blood pressure (SBP), a) sitting SBP: \<90 mmHg, b) sitting SBP: change of \>=30mmHg increase, c) sitting SBP: change of \>=30mmHg decrease, d) supine SBP: change of \>=30mmHg increase, e) supine SBP: change of \>=30mmHg decrease and f) Supine SBP: value \<90mmHg.
Time frame: Baseline up to Week 6
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 1 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 1 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 1 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 1 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 2 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 2 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 1 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 1 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 2 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 0 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 1 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg increase | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Change >= 20mmHg increase | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: change >= 30mmHg increase | 1 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine DBP: Value <50 mmHg | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Change >= 30mmHg decrease | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting DBP: Change >= 20 mm Hg increase | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Sitting SBP: <90mmHg | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Pre-defined Criteria For Vital Signs | Supine SBP: Value <90mmHg | 0 Participants |
Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)
An AE was any untoward medical occurrence in a participant who received investigational product without regard to possibility of causal relationship. SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly; medically important events. Treatment-emergent were events between first dose of investigational product and up to 28 days after the last dose of investigational product that were absent before treatment or that worsened relative to pretreatment state. AEs included both SAEs and all non-SAEs.
Time frame: Baseline (Day 1) up to at least 28 days after last dose of study drug (approximately up to Week 11)
Population: Safety analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug.
| Arm | Measure | Group | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| Vehicle Cream Once Daily (QD) | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 18 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 17 Participants |
| PF-06700841 0.1% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 11 Participants |
| PF-06700841 0.3% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 12 Participants |
| PF-06700841 1.0% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| PF-06700841 3.0% Cream QD | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 10 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| Vehicle Cream Twice Daily (BID) | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 17 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 9 Participants |
| PF-06700841 0.3% Cream BID | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | TEAEs | 14 Participants |
| PF-06700841 1.0% Cream BID | Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) | SAEs | 0 Participants |
Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation
The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch.
Time frame: Baseline, Weeks 1, 2, 3, 4 and 6
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure. NRI method: participants with missing values were considered to be non-responders.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 16.2 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 40.5 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 35.1 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 21.6 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 24.3 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 30.6 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 38.9 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 41.7 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 38.9 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 16.7 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 42.9 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 51.4 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 20.0 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 51.4 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 48.6 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 59.5 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 56.8 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 29.7 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 48.6 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 62.2 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 58.3 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 44.4 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 61.1 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 58.3 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 61.1 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 33.3 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 30.6 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 25.0 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 13.9 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 30.6 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 51.4 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 28.6 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 45.7 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 60.0 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 60.0 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 60.0 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 60.0 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 25.7 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 57.1 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=2 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 37.1 Percentage of participants |
Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation
The severity of itch (pruritus) due to AD was assessed using a horizontal NRS. Participants at specified time points were asked the following question: How would you rate your itch due to AD at the worst moment during the previous 24 hours? The scale ranged from 0-10, where 0= no itch and 10= worst itch imaginable. Higher scores indicated worse itch.
Time frame: Baseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure. NRI method: participants with missing values were considered to be non-responders.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 0.0 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 18.2 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 18.2 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 9.1 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 12.1 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 9.1 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 30.0 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 10.0 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 23.3 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 30.0 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 26.7 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 3.3 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 34.4 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 3.1 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 15.6 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 28.1 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 9.4 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 21.9 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 32.3 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 45.2 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 35.5 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 19.4 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 16.1 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 19.4 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 32.1 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 21.4 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 50.0 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 50.0 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 25.0 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 10.7 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 10.0 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 16.7 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 20.0 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 3.3 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 10.0 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 10.0 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 20.0 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 20.0 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 30.0 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 33.3 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 3.3 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 13.3 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Follow-up visit | 7.4 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 1 | 11.1 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 3 | 37.0 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 4 | 37.0 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 6 | 40.7 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=4 Points Reduction in Peak Pruritus Numerical Rating Scale (PP-NRS) From Baseline at Weeks 1, 2, 3, 4, 6 and Follow-up Visit: Non-responder Imputation | At Week 2 | 33.3 Percentage of participants |
Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation
EASI evaluates severity of participant's AD (excluded scalp, palms, soles) based on severity of AD clinical signs and % of body surface area (BSA) affected. Severity of clinical signs of AD (erythema, induration/papulation, excoriation and lichenification) scored separately for each of 4 body regions(head and neck, upper limbs, trunk \[including axillae and groin\] and lower limbs \[including buttocks\]) on4-point scale: 0= absent; 1= mild; 2= moderate; 3= severe. EASI area score was based upon % BSA with AD in each 4 body region: 0 (0%), 1 (\>0 to \<10%), 2 (10 to \<30%), 3 (30 to \<50%), 4 (50 to \<70%), 5 (70 to \<90%) and 6 (90 to 100%). Total EASI score =0.1\*Ah\*(Eh+Ih+Exh+Lh) + 0.2\*Au\*(Eu+Iu+ExU+Lu) + 0.3\*At\*(Et+It+Ext+Lt) + 0.4\*Al\*(El+Il+Exl+Ll); A = EASI area score; E = erythema; I = induration/papulation; Ex = excoriation; L = lichenification; h = head and neck; u = upper limbs; t = trunk; l = lower limbs. Total EASI score ranged from 0.0 to 72.0, higher scores = greater severity of AD.
Time frame: Baseline, Weeks 1, 2, 3, 4 and 6
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. NRI method: participants with missing values were considered to be non-responders.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 5.4 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 35.1 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 24.3 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 5.4 Percentage of participants |
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 8.1 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 10.8 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 21.6 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 32.4 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 16.2 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 0.0 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 27.8 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 52.8 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 19.4 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 38.9 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 36.1 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 43.2 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 54.1 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 5.4 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 24.3 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 43.2 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 41.7 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 16.7 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 38.9 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 50.0 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 50.0 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 19.4 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 22.2 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 13.9 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 0.0 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 16.7 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 19.4 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 13.9 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 25.0 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 36.1 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 36.1 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 6 | 51.4 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 4 | 48.6 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 1 | 21.6 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 3 | 43.2 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving >=75% Improvement in Eczema Area and Severity Index Total Score (EASI-75) From Baseline at Weeks 1, 2, 3, 4 and 6: Non-responder Imputation | At Week 2 | 32.4 Percentage of participants |
Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation
IGA assesses severity of participant's AD on a 5 point scale. 0= clear, no inflammatory signs of AD; 1= almost clear, AD not fully cleared- light pink residual lesions (except post-inflammatory hyperpigmentation), just perceptible erythema, papulation/induration lichenification, excoriation, and no oozing/crusting; 2= mild AD with light red lesions, slight but definite erythema, papulation/induration, lichenification, excoriation and no oozing/crusting; 3= moderate AD with red lesions, moderate erythema, papulation/induration, lichenification, excoriation and slight oozing/crusting and 4= severe AD with deep dark red lesions, severe erythema, papulation/induration, lichenification, excoriation and moderate to severe oozing/crusting. Higher scores indicating more severity of AD. Assessment excluded soles, palms and scalp.
Time frame: Baseline, Week 6
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Non-Responder Imputation (NRI) method: participants with missing values were considered to be non-responders.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Vehicle Cream Once Daily (QD) | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 10.8 Percentage of participants |
| PF-06700841 0.1% Cream QD | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 29.7 Percentage of participants |
| PF-06700841 0.3% Cream QD | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 33.3 Percentage of participants |
| PF-06700841 1.0% Cream QD | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 40.5 Percentage of participants |
| PF-06700841 3.0% Cream QD | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 44.4 Percentage of participants |
| Vehicle Cream Twice Daily (BID) | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 13.9 Percentage of participants |
| PF-06700841 0.3% Cream BID | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 33.3 Percentage of participants |
| PF-06700841 1.0% Cream BID | Percentage of Participants Achieving Investigator's Global Assessment (IGA) Score Clear (0) or Almost Clear (1) and a Reduction From Baseline of Greater Than or Equal to ( >=2) Points at Week 6: Non-responder Imputation | 27.0 Percentage of participants |
Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit
4 body regions were evaluated: head and neck, upper limbs, trunk (including axillae and groin) and lower limbs (including buttocks). Scalp, palms and soles were excluded. BSA was calculated using handprint method. Number of handprints (size of participant's full palmer hand) fitting in the affected area of a body region was estimated. Maximum number of handprints were 10 for head and neck, 20 for upper limbs, 30 for trunk and 40 for lower limbs. Surface area of body region equivalent to 1 handprint: 1 handprint was equal to 10% for head and neck, 5% for upper limbs, 3.33% for trunk and 2.5% for lower limbs. Percent BSA for a body region was calculated as = total number of handprints in a body region \* % surface area equivalent to 1 handprint. Overall % BSA for an individual: arithmetic mean of % BSA of all 4 body regions, ranged from 0 to 100%, with higher values representing greater severity of AD.
Time frame: Baseline, Weeks 1, 2, 3, 4, 6 and follow up visit (28 days after last dose of study drug = maximum up to Day 71)
Population: Full analysis set included all participants who were randomly assigned to study drug and who applied at least 1 dose of study drug. Here, Overall Number of Participants Analyzed signifies participants evaluable for this outcome measure and number analyzed signifies participants evaluable for the each specified time point.
| Arm | Measure | Group | Value (LEAST_SQUARES_MEAN) |
|---|---|---|---|
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -23.6 Percent change |
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -2.4 Percent change |
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -15.3 Percent change |
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -17.1 Percent change |
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -21.6 Percent change |
| Vehicle Cream Once Daily (QD) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -25.9 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -13.1 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -2.9 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -20.1 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -24.5 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -7.2 Percent change |
| PF-06700841 0.1% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -39.4 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -59.4 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -50.6 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -38.1 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -55.8 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -42.7 Percent change |
| PF-06700841 0.3% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -16.2 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -63.6 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -19.9 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -43.6 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -55.9 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -57.9 Percent change |
| PF-06700841 1.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -37.0 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -60.3 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -39.0 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -55.2 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -23.0 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -56.7 Percent change |
| PF-06700841 3.0% Cream QD | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -49.2 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -25.2 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -34.7 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -2.5 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -31.2 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | 8.5 Percent change |
| Vehicle Cream Twice Daily (BID) | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -26.3 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -46.4 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -48.9 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -16.5 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -39.8 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -31.6 Percent change |
| PF-06700841 0.3% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -34.2 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 4 | -57.7 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 3 | -44.0 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Follow-up visit | -24.6 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 6 | -65.0 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 1 | -17.0 Percent change |
| PF-06700841 1.0% Cream BID | Percent Change From Baseline in Affected Body Surface Area (BSA) at Weeks 1, 2, 3, 4, 6 and Follow-up Visit | At Week 2 | -43.1 Percent change |